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Abstract 
Reproductive function is regulated through the hypothalamic-pituitary-gonadal (HPG) 
axis. Gonadotropin-releasing hormone (GnRH) neurons form final commons pathway 
that integrates inputs and releases GnRH, which then stimulates downstream elements 
of the HPG axis. Several factors can alter GnRH neuron output and thus reproductive 
function. One such signal is stress. Stress activates several pathways including the 
hypothalamic-pituitary-adrenal (HPA) axis. Corticotropin-releasing hormone (CRH) is 
released in response to activation of HPA axis and has been shown in several studies 
to be involved in stress-induced alteration of reproductive function. In this dissertation, 
our central hypothesis is that CRH acts on the HPG axis to alter GnRH neuron activity. 
To determine if CRH modifies firing activity of GnRH neurons, we performed 
extracellular recordings of GFP-identified GnRH neurons before and during CRH 
treatment. Several studies suggested that the interactions between HPA and HPG axes 
are modulated by estradiol. Therefore, GnRH neurons were recorded from 
ovariectomized mice either with an estradiol capsule implanted (OVX+E) or not treated 
further (OVX) to determine the influence of estradiol on the GnRH neuron response to 
CRH. In OVX mice, CRH did not affect GnRH neuron activity. In contrast, CRH 
displayed dose-dependent stimulatory and inhibitory effects on firing frequency of GnRH 
neurons in brain slices from OVX+E mice. This suggested that estradiol is required for 
CRH to alter GnRH neuron activity. The dose-dependent effects of CRH resulted from 
the activation of different CRH receptors. A CRH receptor (CRHR)-1 agonist increased 
firing activity in GnRH neurons, whereas activation of CRHR-2 led to decrease in firing 
frequency. We further analyzed if CRH alter short-term burst firing patterns, which has 
been associated with hormone secretion from neuroendocrine cells. We found that CRH 
affected burst frequency and other properties, including burst duration, spikes/burst, 
and/or intraburst interval. These results indicate that GnRH neuron activity is regulated 
by CRH. We further explored how CRH acts on GnRH neurons both through indirect 
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and direct mechanisms. First, we tested if CRH has an acute effect on activity of 
arcuate kisspeptin neurons, which provide estradiol-sensitive activation of GnRH 
neurons. CRH did not acutely alter firing rate of arcuate kisspeptin neurons in either 
OVX or OVX+E (both daily surge and low E models) mice. Second, we tested if 
GABAergic inputs, which is a major excitatory fast synaptic transmission to GnRH 
neurons, are influenced by CRH. Activation of CRHR-1 increased GABAergic 
postsynaptic current frequency in GnRH neurons from OVX+E, whereas activation of 
CRHR-2 showed no effect. This increase in GABAergic inputs was not observed in 
GnRH neurons from OVX mice treated with CRHR-1 agonist. This implies that CRH 
stimulate GnRH neuron activity by increasing GABAergic inputs to GnRH neurons and 
this effect is also estradiol-dependent. Third, we tested the direct action of CRH on 
GnRH neuron voltage-gated potassium currents, which play roles in regulating resting 
membrane potential and excitability of GnRH neurons. The amplitude of fast transient 
and sustained potassium currents in GnRH neurons from OVX+E was not affected by 
either activation of CRHR-1 or CRHR-2. Fourth, the direct action of CRH on GnRH 
neuron excitability was tested. No differences were observed in action potential firing in 
response to current injection from GnRH neurons treated with CRH. Overall, these data 
suggest that CRH exerts both stimulatory and inhibitory on GnRH neuron firing activity 
and the CRH is likely act on GnRH neurons through indirect mechanisms. 
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Chapter 1: Introduction 
Overview  
Reproduction is required to maintain species. In vertebrates, reproduction is controlled 
by the hypothalamo-pituitary-gonadal (HPG) axis. This axis is regulated by a number of 
external and internal inputs, such as season, food availability, age, and stress. The last 
of these is regulated by another neuroendocrine axis, the hypothalamo-pituitary-adrenal 
(HPA) axis, along with other central and peripheral elements. This introduction will focus 
on how different levels of the HPG and HPA axes interact, and how stress affects 
reproduction, in particular at the central level. 
 
The HPG axis 
Gonadotropin-releasing hormone (GnRH) neurons form the final common pathway that 
integrates inputs and releases hormone to control reproductive processes in 
vertebrates. The somata of GnRH neurons are located in the midventral preoptic area 
(POA) and hypothalamus and most project to the median eminence where GnRH is 
released near the primary capillaries of the hypophyseal portal system (1). There are 
two modes of GnRH release, pulse and surge. Pulsatile release of GnRH occurs during 
the majority of the female reproductive cycle and is the only known mode of release in 
males (2,3). At the end of follicular phase in females, GnRH release switches from 
pulsatile to surge mode, which in most species is critical for ovulation (4-7). GnRH binds 
to receptors on gonadotropes in the anterior pituitary gland, where it stimulates 
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synthesis and secretion of the gonadotropins, luteinizing hormone (LH) and follicle-
stimulating hormone (FSH), from these cells (8-10). LH and FSH activate gonadal cells, 
regulating gametogenesis and steroidogenesis. Gonadal steroids feed back to the brain 
and pituitary to regulate GnRH and gonadotropin secretion, respectively (11-14).  
 
There are two modes of release for GnRH, pulse and surge. Pulsatile release of GnRH 
occurs during the majority of female reproductive cycle and is the only mode of release 
in males. Daily measurement of LH showed that the LH level is fairly constant 
throughout the menstrual cycle with the exception of a preovulatory peak of LH, called a 
surge (15). With the development of radioimmunoassays it became possible to assay 
more frequent blood samples. Sampling at 10-min intervals from ovariectomized (OVX) 
monkeys revealed a pulsatile pattern with intervals between subsequent LH peaks 
around 60 minutes (16). Frequent sampling from pituitary portal blood in ewes revealed 
the LH pulse pattern mirrored that of GnRH (2,17). The pulsatile secretion of GnRH is 
necessary to maintain release of LH and FSH as shown by Belchetz and colleagues in 
1978. In this study, endogenous release of GnRH was eliminated by ablation of the 
medial basal hypothalamus and GnRH was administered in a pulsatile or continuous 
manner. Continuous treatment with GnRH inhibited both LH and FSH secretion 
whereas pulsatile treatment of GnRH restored release of the gonadotropins (18). This 
emphasizes the importance of GnRH release pattern for reproductive function. 
 
The frequency of GnRH release varies during the cycle with the changes in sex steroid 
hormones. Low level of estradiol during the majority of the cycle exerts negative 
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feedback effect on GnRH pules. The rise in estradiol levels as the ovarian cycle 
proceeds decreases GnRH/LH pulse amplitude but increases GnRH/LH pulse 
frequency (4,19). Estradiol also exerts an inhibitory effect at the pituitary level by 
suppressing response to GnRH stimulus in gonadotrophs (20,21). At the end of follicular 
phase, exposure to sustained high levels of estradiol initiates a switch from negative to 
positive feedback action and induces a GnRH surge during which release is continuous 
for many hours (4-6,22). The surge of GnRH induces LH surge that triggers ovulation 
(4-6,22). In primates, however, a surge of GnRH is not always required for the LH surge 
to occur. Exogenous treatment with pulsatile GnRH in monkeys with hypothalamic 
lesions or women with primary amenorrhea restored the menstrual cycle and ovulation; 
this is likely attributable to estradiol-mediated increases in response to GnRH at the 
pituitary being sufficient to generate a preovulatory surge (23,24). After ovulation, a 
corpus luteum is formed from remaining follicular tissues, marking the beginning of the 
luteal phase of the cycle. During this phase, high progesterone has negative feedback 
effects on GnRH pulse frequency (25,26). Progesterone and estradiol act together to 
suppress GnRH pulse frequency; the inhibitory effect of progesterone is estradiol-
dependent as expression of the progesterone receptor requires estradiol (26-30). In the 
absence of pregnancy, the corpus luteum is degraded, decreasing circulating 
progesterone and its negative feedback action, leading to an acceleration of pulsatile 
release and the start of a new follicular phase.  
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Stress and the HPA axis 
In 1936, Hans Selye first defined ‘general adaptation syndrome’ (31), which was later 
renamed ‘stress’. General adaptation syndrome referred to ‘the non-specific 
neuroendocrine response of the body’ to a noxious insult (32). Stress activates several 
pathways to help maintain homeostasis in these circumstances. The major pathways 
are a noradrenergic pathway in the locus coeruleus, epinephrine release from the 
adrenal medulla, and the hypothalamo-pituitary-adrenal (HPA) axis, which regulates the 
synthesis of glucocorticoids (reviewed in (33,34)). This study will focus primarily on the 
relationship between the HPA and HPG axes.  
 
Corticotropin-releasing hormone (CRH), a 41-amino-acid peptide sequenced in 1981, 
plays a major role in the stress response (35). CRH regulates the HPA axis and is 
synthesized and released from neurons in the parvocellular subdivision of the 
paraventricular nucleus (PVN) of the hypothalamus. Of note, CRH is also expressed in 
other parts of the brain, such as the central nucleus of amygdala and hindbrain regions, 
which control the autonomic response to stress (36). Arginine vasopressin (AVP) is also 
synthesized in the parvocellular PVN and can augment the response to CRH (37). 
Magnocellular neurons in PVN and supraoptic nucleus also release AVP, typically in 
response increase in blood osmolarity (38); this source does not appear to be involved 
in the stress response, likely because CRH is not being co-released. CRH acts on 
pituitary corticotropes to stimulate secretion of adrenocorticotropic hormone (ACTH) 
(39,40), which ultimately triggers the synthesis of glucocorticoids (mainly 
corticosterone/cortisol) by the adrenal cortex (detailed review in (41)). Glucocorticoids 
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exert negative feedback effects on the pituitary and hypothalamus to regulate the 
activity of the HPA axis (42).  
 
CRH receptors and other ligands 
CRH receptors are class-B G-protein-coupled receptors (43,44). There are two major 
types of CRH receptors (CRHR), CRHR-1 and CRHR-2, which share 70% amino acid 
homology (45). The distribution of these two receptors is different. CRHR-1 is 
expressed primarily and widely in the brain, in regions including the cerebral cortex, 
amygdala, hippocampus, and hypothalamus, as well as in pituitary corticotropes 
(45,46). CRHR-2 is expressed mostly in peripheral tissues including heart and skeletal 
muscle, as well as in the lateral septum and hypothalamus (45,46). In addition to CRH, 
these receptors also bind a family of three CRH-related peptides called urocortins 
(47,48). CRH and the urocortins bind to CRHRs with different affinities. CRHR-1 has a 
higher affinity for CRH than CRHR-2 (IC50 = CRHR-1 1.6nM, CRHR-2 42nM) (49), but 
both receptors bind urocortin I with similar, and higher, affinity (IC50 = CRHR-1 0.16nM, 
CRHR-2 0.86nM) (49). Both urocortin II and urocortin III are considered to be 
endogenous ligands of CRHR2 due to the high affinity of CRHR-2 for these two 
peptides. Urocortin II and II have been used as tools to test independent activation of 
this subtype as CRHR-1 has little to no affinity for these peptides (48). The endogenous 
role of urocortins with regard to the regulation of HPA axis has been discussed in (50). 
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The HPA axis response to stress  
When stress occurs, CRH is released near the hypophyseal portal vessels, and binds to 
CRHR-1 on corticotropes to drive downstream activity of the HPA axis. The role of 
CRHR-1 in the stress response was confirmed in CRHR-1-deficient mice, which exhibit 
an impaired stress response with minimal ACTH release and little to no corticosterone 
production (51). These mice also have reduced anxiety-related behaviors (52,53). In 
contrast, mice that lack urocortin I, which also binds with CRHR-1, had a normal 
corticosterone rise in response to restraint stress (54), despite the demonstrated ability 
of this peptide to increase glucocorticoids when exogenously administered (47). These 
observations imply that CRH and not urocortin I is the primary endogenous regulator of 
the CRHR-1-mediated stress response of the HPA axis, although redundancy in this 
system cannot be excluded. 
 
Compared to CRHR-1, the function of CRHR-2 in the stress response is more complex. 
One hypothesis is that CRHR-2 acts to counteract the functions of CRHR-1 by 
lessening the stress response (55). Consistent with this, mice lacking CRHR-2 exhibit 
hypersensitivity to stress induction and a slower return of corticosterone to pre-stress 
levels (56,57). These results suggest that CRHR-1 and CRHR-2 might be responsible 
for different physiological responses during stress. This is of interest to interactions 
between the HPA and HPG axes, because while stress has been reported to primarily 
inhibit various reproductive processes, activation has also been observed. Of note, 
intracerebroventricular (icv) or intravenous injection of urocortin III (which binds 
exclusively to CRHR-2) increased ACTH and corticosterone levels compared to the 
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control group (58), suggesting activation of CRHR-2 can also initiate HPA axis activity; 
whether or not this occurs during stress in response to endogenously released urocortin 
III is not known.  
 
Inhibitory effects of stress on reproduction  
Deleterious effects of stress exposure on reproductive function have been 
demonstrated in several species (59-62). Several modalities for inducing a stress 
response have been used, including metabolic, immunological, psychosocial, and 
physical; these stressors alter timing of puberty in both males and females (63-67), and 
disrupt reproductive cycles in female (68-73). A likely factor contributing to altered 
reproduction is an underlying disruption of gonadotropin secretion. In particular, the 
effects of stress or HPA hormones on LH release have been informative, as the 
frequency of pulses provides a window to the central aspects of HPG axis function. It is 
important to keep in mind that stress induction and components of the HPA axis (CRH, 
ACTH, and glucocorticoids) are not equivalent. Stress induction stimulates multiple 
pathways, which includes but is not limited to the HPA axis. Nonetheless, treatments 
blocking response to or mimicking action of different components of the HPA axis have 
been useful in identifying their roles in stress-induced changes. 
 
Glucocorticoids, the end organ product of HPA axis activation, typically suppress 
gonadotropin secretion, but data vary, and several factors need to be considered when 
interpreting these results. In ovariectomized (OVX) ewes, cortisol treatment that mimics 
the levels achieved during immunological stress suppresses LH pulse amplitude but not 
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frequency (73,74); this same cortisol treatment had no effect on GnRH pulse amplitude 
or frequency (74), indicating cortisol acts at the pituitary in this model to inhibit the 
response to GnRH, rather than centrally to affect its release. In contrast, cortisol 
suppressed both GnRH and LH pulse frequency in follicular phase ewes (61,75,76). 
This suggests that circulating ovarian steroids present in the latter study may influence 
the response of the HPG axis during stress; this will be discussed in detail below. In 
OVX female rats with low physiological estradiol replacement resembling diestrous 
levels, neither acute nor chronic treatment with corticosterone altered LH pulse 
frequency or amplitude (65,77), whereas in intact male rats chronic corticosterone 
treatment lowered serum LH levels in single terminal samples (78). The difference in LH 
response between these studies may be attributable to sex, corticosterone dose, which 
was lower in the former, and/or LH sampling regimen. In castrated male monkeys, 
chronic cortisol treatment suppressed LH and FSH in daily or alternate daily samples 
(79). This suppression is likely at the hypothalamic level because pituitary response to 
GnRH treatment was not affected. In early-follicular-phase women, chronic 
hydrocortisone treatment suppressed LH pulse frequency (62), whereas acute 
treatment on the day of sampling did not affect either LH or FSH levels in either early 
follicular phase women or in men (80). Here the discrepancy in results might be due to 
treatment duration or to different blood sampling intervals affecting the ability to detect 
LH pulses. Glucocorticoids thus suppress LH secretion in most conditions but the 
mechanisms (central vs pituitary) depend on the species, duration of treatment, and 
gonadal steroids. 
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The effects of CRH on gonadotropes and GnRH neuron output also vary with model 
studied. Inhibitory effects of CRH administered ICV or into the median eminence on LH 
pulse frequency and amplitude have been observed in monkeys and rats (81-83). While 
a critical role of CRH signaling in this scenario is likely to induce a glucocorticoid rise, 
intravenous injection of CRH inhibited LH pulse frequency and amplitude in 
adrenalectomized monkeys despite these animals being unable to produce adrenal 
glucocorticoids (83). This indicates that CRH itself can act on the reproductive system 
independent of glucocorticoids. CRH mediates stress effects on LH secretion, at least in 
part, as pretreatment with non-specific CRHR antagonists prevents stress-induced 
suppression of LH pulses in castrated male rats, OVX+E rats, and OVX monkeys 
(60,81,84,85). In vivo treatment of OVX+E rats with CRHR-1- or CRHR-2-specific 
antagonists revealed that different types of stressors act on the reproductive system via 
different CRHR subtypes; insulin-induced hypoglycemia and immunological stress act 
through CRHR-2, whereas restraint-induced stress occurs through both CRHR-1 and 
CRHR-2 (85). Administration of a CRHR-2 antagonist, astressin-2B, ameliorated the 
effect of restraint stress on LH pulse suppression but not the stress-induced 
corticosterone rise (86). In a complementary study, ICV administration of the CRHR-2-
specific agonist urocortin II suppressed LH pulse frequency, but this effect was delayed 
by over an hour compared to the effect of stress, suggesting other systems activated by 
stress have a more rapid effect. An anti-urocortin II antibody blocked the inhibitory effect 
of restraint stress on LH in single point samples but did not alter either ACTH or 
corticosterone levels (87), suggesting that urocortin II could act at the central level. 
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Stimulatory effects of stress on reproduction 
Stress exerts stimulatory effects on the reproductive system in some conditions. Several 
lines of evidence indicate CRH itself may activate the HPG axis. First, ICV 
administration of CRH in either male or female gonadectomized steroid-replaced sheep 
increased LH pulse frequency (88). Second, pretreatment with a CRHR antagonist that 
blocks both CRHR-1 and CRHR-2 prevented the stimulatory effect of interleukin-1 (IL-
1), which mimics immune-mediated stress, on LH secretion in OVX+E monkeys (89). 
Third, pretreatment with a CRHR-1, but not CRHR-2, antagonist abolished the 
stimulatory effect of acute restraint stress on LH pulses in female rats, implying different 
consequences of activating these receptors (90,91). Fourth, in male rats, the initial 
exposure to restraint stress increased plasma LH levels within 15-30 min of stress 
onset, after which levels declined toward pre-stress baseline (92). This acute increase 
in LH secretion disappeared after 10 days of exposure to the same stress, suggesting a 
change in the response to stress over time (92). Together these observations suggest 
that under certain conditions, CRH can enhance LH secretion via CRHR-1. 
 
Stimulatory effects of stress sometimes occur in a subset of animals. For example, 
examination of the individual rat data in (86) revealed that restraint stress during CRHR-
2 antagonist treatment caused a transient increase in LH pulse amplitude in the 
representative data shown; whether or not this was a consistent observation is not 
known. Similarly, one of four monkeys subjected to 6h restraint showed increased LH 
pulse frequency and amplitude within 30 min of stress onset during both follicular and 
luteal phases (93). Intravenous injection of CRH caused premature hypothalamic 
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multiunit activity (MUA) volleys in 5 of 15 OVX monkeys tested (82); these data were 
noted to be excluded by the authors despite one third of animals exhibiting this 
response. If such observations are regarded as technical errors and excluded from the 
analysis, this could alter interpretation of the complete effects of stress on reproduction, 
in particular variations between stress-susceptible and stress-resilient subpopulations. 
These data point to potential biphasic effects of stress on reproductive neuroendocrine 
function with an initial stimulation followed by suppression. 
 
Influence of sex steroid hormones on stress response  
It is well established that sex differences exist in HPA axis function both under 
unstressed control conditions and during the stress response. Female rats produce both 
greater basal levels and greater increases in ACTH and corticosterone in response to 
stress than males (94,95). There are several factors that may underlie these sex 
differences, including gonadal steroid hormones. In this regard, estradiol can alter the 
function of the HPA axis at every level. CRH neurons express ERß (96,97) thus can 
respond directly to estradiol as well as be influenced via steroid-sensitive afferents. 
During unstressed conditions, rats with high circulating estradiol (OVX+E and proestrus) 
had higher basal ACTH and corticosterone levels (98,99); the corticosterone rise in 
response to stress was also greater in these animals compared to OVX or diestrous rats 
(98,100). CRH mRNA expression in the PVN is higher in OVX+E than OVX rats (77,99); 
further, basal CRHR-1 and CRHR-2 mRNA expression in the dorsal raphe was also 
higher in female than male rats (101). Stress-induced expression of CRHR-1 was 
greater during the morning of proestrus than diestrus, and removal of ovaries decreased 
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CRHR-1 and CRHR-2 mRNA expression in female rats, suggesting estradiol plays a 
role in regulation of CRHR expression (102,103). Both CRH and CRHR genes contain 
estrogen-responsive elements (104,105). Estradiol-induced increases in CRH and 
CRHR could thus prime the central arm of the HPA axis to produce a greater output in 
response to stress, and upregulate target tissue response, respectively.  
 
In contrast to estradiol, androgens typically suppress the stress response. Castrated 
males produce a greater corticosterone rise in response to stress than intact males in 
several species (94,106,107). Androgen replacement by dihydrotestosterone (DHT), a 
non-aromatizable androgen, restored the corticosterone rise to that observed in intact 
male rats (107). The increase in corticosterone secretion observed in castrated males 
might be attributable to central effects of steroids as castrated rats have increased basal 
hypothalamic tissue CRH levels and increased CRH immunoreactivity in the PVN 
compared to intact rats (108). DHT replacement reduced stress-induced activation of 
neuroendocrine cells detected by cfos expression in the PVN (intact males were not 
examined) and also suppressed CRH and AVP mRNA expression in the PVN compared 
to unreplaced castrated rats (109). Together, these results indicate that androgens often 
play an opposite role to estrogens and that sex steroids are an underlying cause in sex 
differences in the stress response. 
 
The effects of stress on the reproductive system are also influenced by gonadal steroid 
hormones. In rats, the inhibitory effects of insulin-induced hypoglycemia and food 
deprivation on LH pulse frequency were stronger in OVX+E than OVX rats 
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(77,110,111). Immunological challenge with IL-1 in female monkeys during the mid-
follicular phase generated a robust increase in the mean circulating LH concentration 
five hours after injection, whereas similar treatment in early follicular phase monkeys, 
which have lower estradiol, had no effect, and the same treatment in OVX monkeys 
suppressed LH (112-114). In postmenopausal women receiving transdermal estradiol 
replacement, inflammatory stress or ACTH infusion increased mean hourly plasma LH 
concentrations 3-fold compared to baseline (115). Together these observations suggest 
gonadal steroids might dictate the direction of the effects of immune stress on 
gonadotropin secretion. 
 
Estradiol may augment effects of stress by amplifying the actions of CRH. OVX+E rats 
exhibit a stronger suppressive effect of CRH on LH pulse amplitude and frequency than 
OVX rats (81). The inhibitory effects of CRH on GnRH mRNA expression in GnRH-
producing immortalized hypothalamic GT1-7 cells is greater with estradiol co-treatment 
(116). The inhibitory effect of corticosterone is also influenced by estradiol as chronic 
corticosterone treatment suppressed LH pulse frequency and amplitude and decreased 
cfos expression (as a marker of neural activation) in arcuate kisspeptin neurons in 
OVX+E but not in OVX mice (117). Together, these data suggest that estradiol 
potentiates the effects of stress on the reproductive system, indicating bidirectional 
interactions between the HPG and HPA axes. 
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Effects of stress on the GnRH/LH surge 
In addition to disruptions of homeostatic feedback, stress can interfere with estradiol 
positive feedback needed to generate ovulation. In rats, restraint for 5-7 hours starting 
0-2 hours before the typical onset of the LH surge blocked the surge in half of the 
animals and decreased ovulation rate (118). In mice, the LH surge was blocked in a 
majority of animals in response to application of an acute psychosocial stress paradigm 
on the morning of proestrus. An LH surge was also not detected on the next day 
suggesting that stress did not delay LH surge by 24h, but either completely blocked the 
generation of the LH surge or altered its timing sufficiently to be out of the sampling 
window (119). That this stress-induced effect was on estradiol action, not production of 
the estradiol rise, is demonstrated by two observations. First, uteri of stressed mice 
were similar size to controls and uterine mass is directly correlated with estradiol levels 
(120). Second, the estradiol-induced LH surge was also blocked. 
 
Glucocorticoids released during the stress response may inhibit the LH surge. Cortisol 
infusion in ewes during the early-to-mid follicular phase blocked the LH surge in half of 
the animals and delayed the surge in the remainder (75). The effects on the LH surge 
might result from the reduced or absent follicular phase estradiol rise attributable to 
suppressed pulsatile release (75). Further experiments, however, showed suppressive 
effects of cortisol on the estradiol-induced LH surge in both sheep and mice 
(69,121,122), indicating an additional effect of glucocorticoids to interrupt the positive 
feedback effects of estradiol. CRH might also be involved in stress-induced suppression 
of the LH surge. Continuous infusion of CRH for six hours starting an hour before the 
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typical onset of the LH surge or a single injection of CRH five minutes before typical 
surge onset reduced LH surge amplitude in proestrous rats (123). CRH-deficient mice, 
however, showed typical suppression of the LH surge by restraint stress (124), 
suggesting CRH might not be the only contributor in the stress-induced suppression of 
LH. 
Possible central mechanisms of stress-reproductive interactions 
GnRH neurons 
Several studies suggest that GnRH neurons could be a direct target for CRH. 
Anatomical evidence showed that CRH-containing fibers in humans (125) and rats 
appose GnRH neuron cell bodies (126). To ask if effects of CRH may be direct on 
GnRH neurons, several labs have examined CRHR expression in these cells, but 
results are mixed. Immortalized GT1-7 cells express CRHR-2 and this expression is 
enhanced by estradiol (116). Single-cell RT-PCR analysis showed CRHR-1 mRNA in 
one-fourth of GnRH neurons from female mice and approximately 30% of GnRH 
neurons exhibited CRHR immunoreactivity although the antibody used did not 
distinguish between CRHR subtypes (127). Neither CRHR-1 nor CRHR-2 mRNA were 
enriched in GnRH neurons from male (intact or castrated) or female (diestrous or OVX) 
mice determined by translating ribosome affinity purification (128); lack of enrichment 
does not indicate absence and this method has reduced sensitivity with low copy-
number transcripts such as GPCRs. Of note, CRHRs were not detected in cells 
identified as GnRH neurons from male and female mice determined by the single-cell 
RNA-seq transcriptional profiling but this approach may lack the necessary sequencing 
depth (129). In situ hybridization in female rats and male mice also did not detect either 
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CRHR-1 or CRHR-2 in GnRH neurons (130,131). These discrepancies might result 
from the species, sex, and methodical differences in each study. Cholera toxin injected 
into the third ventricle labels GnRH neurons among many cell types, but none of these 
labeled cells projected to CRH neurons (130). Together these results indicate 
expression of CRHR by GnRH neurons remains controversial. Even if CRHR is 
confirmed in GnRH neurons, the effects of stress on these cells can also be through 
intermediate neurons and/or through non-HPA stress pathways. 
 
Despite the difficulties in confirming CRHR expression in GnRH neurons, functional 
studies suggest that GnRH neurons are direct and/or indirect targets for stress. 
Follicular phase monkeys that were classified as stress-sensitive (exhibited suppression 
of menstrual cycles and sex steroid levels during the first cycle of stress exposure) had 
less GnRH fiber immunostaining in the median eminence, but a higher number of 
neurons expressing GnRH mRNA in the medial basal hypothalamus, compared to 
monkeys that were resistant to stressors (continued to show normal menstrual cycles 
and changes in sex steroids) (132). This suggests that stress could alter transportation 
of GnRH from cell bodies to axon terminals, thus decreasing the releasable pool of 
GnRH. CRH acutely suppressed hypothalamic MUA volleys concomitant with the 
suppression of LH pulse frequency in two-thirds of monkeys tested (82), indicating an 
inhibitory action of CRH at the hypothalamic level.  
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Kisspeptin neurons 
GnRH neuron activity and the response to stress are regulated by feedback signaling 
from sex steroid hormones. Since GnRH neurons do not express detectable levels of 
most steroid receptors (133-136), it is likely that sex steroid feedback is mediated by 
steroid-sensitive afferent neurons; steroid modulation of the stress response likely also 
occurs via afferents. Kisspeptin neurons are a major candidate as they express 
estrogen receptor a (ERa) (137) and play a role in negative and positive estradiol 
feedback on the HPG axis (138,139). Kisspeptin is a potent activator of GnRH neuron 
activity, and GnRH and gonadotropin release (140-143). In rodents, kisspeptin neurons 
are found in two major regions in the hypothalamus: the anteroventral periventricular 
(AVPV) nucleus and the arcuate nucleus (144).  
 
With regard to the stress response, immunological and metabolic stresses decrease 
Kiss1 and Kiss1r expression in hypothalamus of male mice and female rats (65,145-
147). Although acute restraint stress did not change the number of Kiss1-expressing 
cells in the arcuate, activation of arcuate kisspeptin neurons as measured by cfos 
expression decreased after restraint stress in both male and female mice (148,149). 
This suggests that multiple aspects of kisspeptin neurons could be targeted by stress 
depending on the paradigm used. The effect of stress on Kiss1 expression might be 
mediated through CRH and/or corticosterone as administration of either substance had 
similar inhibitory effects on hypothalamic Kiss1 expression (65). One 
immunofluorescence study showed that both AVPV and arcuate kisspeptin neurons 
express CRHR (subtype not identified) but that only AVPV kisspeptin neurons express 
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glucocorticoid receptors (150). Another study examined expression of GFP driven by 
the CRHR-1 promoter and indicated expression of CRHR-1 in AVPV kisspeptin neurons 
(151), but the expression of CRHR in arcuate kisspeptin neurons awaits confirmation. 
Retrograde viral tracing failed to identify CRH neurons in the PVN as afferents of 
arcuate kisspeptin neurons (152). Further studies are needed to determine if arcuate 
kisspeptin neuron activity is regulated by CRH and other systems activated by stress. 
 
GABAergic signaling 
Gamma-aminobutyric acid (GABA) is one of the major regulators of GnRH neurons. In 
contrast to most neurons, GABA is typically an excitatory input to GnRH neurons due to 
the high intracellular concentration of Cl- in these cells (153,154). GABAergic inputs to 
GnRH neurons are modified by several factors including pubertal developmental, 
steroids, and metabolic status (155-158). Various stressors increased activity of 
GABAergic neurons detected by cfos expression in the medial preoptic area (mPOA) 
(159-161), where GnRH neurons reside, but whether or not these are direct afferents of 
GnRH neurons is not known. Pretreatment with GABAA or GABAB antagonists in the 
mPOA or arcuate nucleus prevented the inhibitory effect of restraint or immunological 
stress, and CRH treatment on LH pulse frequency (162,163). This indicates that 
GABAergic signaling is necessary for stress or CRH to alter LH secretion. Moreover, 
administration of CRH to the bed nucleus of the stria terminalis or locus coeruleus 
increased neuronal activity measured by cfos expression in GAD67-identified 
GABAergic neurons in the mPOA (164,165). Therefore, it is possible that stress 
modulates GABAergic signaling to GnRH neurons via CRH signaling.  
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Gonadotropin-inhibitory hormone (GnIH) neurons 
The discovery of an inhibitory regulator of GnRH neurons in 2000 by Tsutsui and 
colleagues identified another pathway involved in regulating the HPG axis (166). GnIH 
was first discovered in birds and named based on its physiological function. GnIH was 
later identified in other species; because it shares a structure of LPXRFamide (where X 
is L or Q), GnIH is known as RFamide-related peptide-3 (RFRP-3) in mammals. GnIH 
neurons project to GnRH neurons and inhibit activity of GnRH neurons via GnIH 
receptors (167,168). In addition to possible direct action at GnRH cell bodies, GnIH 
neurons also project to the median eminence and GnIH inhibits gonadotropin secretion 
from the pituitary (169). GnIH neurons express ERα and androgen receptors in female 
and male hamsters, respectively (168), thus can respond directly to sex steroids.  
 
Recently, GnIH was shown to be a possible link between the HPA and HPG axes. The 
first evidence that supported this hypothesis was that GnIH expression is increased by 
stress in sparrows (170). Later, acute and chronic immobilization stress were shown to 
upregulate GnIH expression in the dorsomedial hypothalamic area in male rats (171). 
Further, GnIH expression was negatively correlated to plasma LH concentration. Stress 
also increases cfos expression in GnIH neurons in male and female mice and in ewes 
(148,149,172). Together, these data support the hypothesis that GnIH can mediate 
stress-induced inhibition of LH release. It is important to note that metabolic stress did 
not affect GnIH expression or activation of GnIH neurons (173). Therefore, GnIH might 
mediate some but not all inhibitory effect of stress on the HPG axis. Stress might act on 
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GnIH neurons via CRH and/or corticosterone due to the presence of both CRHR and 
glucocorticoid receptors in these cells (171). However, physiological studies on the 
mechanisms of stress and GnIH are still needed. 
 
Dissertation preview 
Prior to the studies in this dissertation, research in the field of stress and reproduction 
focused on the effects of stress on gene/protein expression or the GnRH/LH release. 
Our main goal is to study the mechanisms of how stress acts via CRH peptide on 
central components of HPG axis. Chapter 2 focuses on the effects of CRH on GnRH 
neuron firing activity and the influence of estradiol on the actions of CRH. Chapter 3 
investigates the possible mechanisms of how CRH acts on GnRH neurons. This 
includes indirect mechanisms via neuromodulators and fast synaptic transmission to 
GnRH neurons and direct action on GnRH neurons. Chapter 4 summarizes the findings, 
discusses the results, proposes the future directions of the studies. Together, these 
studies provide the insight of how stress alters reproductive functions via the 
interactions between CRH and components of HPG axis.
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Chapter 2: Estradiol-dependent Stimulation and Suppression of Gonadotropin-
releasing Hormone (GnRH) Neuron Firing Activity by Corticotropin-releasing 
Hormone (CRH) in Female Mice 
 
The work in this chapter was originally published in the journal Endocrinology January 
2018, 159(1): 414-425 
 
Abstract  
GnRH neurons are the final central regulators of reproduction, integrating various inputs 
that modulate fertility. Stress typically inhibits reproduction but can be stimulatory; stress 
effects can also be modulated by steroid milieu. CRH released during the stress 
response may suppress reproduction independent of downstream glucocorticoids. We 
hypothesized CRH suppresses fertility by decreasing GnRH neuron firing activity. To 
test this, mice were ovariectomized and either implanted with an estradiol capsule 
(OVX+E) or not treated further (OVX) to examine the influence of estradiol on GnRH 
neuron response to CRH. Targeted extracellular recordings were used to record firing 
activity from green fluorescent protein (GFP)-identified GnRH neurons in brain slices 
before and during CRH treatment; recordings were done in the afternoon when estradiol 
has a positive feedback effect to increase GnRH neuron firing. In OVX mice, CRH did 
not affect the firing rate of GnRH neurons. In contrast, CRH exhibited dose-dependent 
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stimulatory (30 nM) or inhibitory (100 nM) effects on GnRH neuron firing activity in 
OVX+E mice; both effects were reversible. The dose-dependent effects of CRH appear 
to result from activation of different receptor populations; a CRHR-1 agonist increased 
firing activity in GnRH neurons, whereas a CRHR-2 agonist decreased firing activity. 
CRH and specific agonists also differentially regulated short-term burst frequency and 
burst properties, including burst duration, spikes/burst and/or intraburst interval. These 
results indicate that CRH alters GnRH neuron activity and that estradiol is required for 
CRH to exert both stimulatory and inhibitory effects on GnRH neurons. 
 
Precis 
CRH exerts both stimulatory and inhibitory effects on GnRH neuron firing activity via 
activation of different receptors in an estradiol-dependent manner. 
 
Introduction 
GnRH neurons are crucial regulators of the reproductive system. GnRH pulses 
stimulate secretion of the gonadotropins, LH and FSH, which then induce the gonads to 
activate gametogenesis and steroidogenesis. GnRH release at the median eminence 
typically requires action potential firing (174). Many factors that alter GnRH neuron 
action potential firing regulate fertility (12,175,176). Stress is one of these factors. In 
some cases, acute stress can stimulate the reproductive system (90,177,178). The vast 
majority of studies, however, suggest that stress exposure suppresses reproductive 
function. Various types of stressors suppress LH pulses in several species, including 
rats (77,163), monkeys (93,179,180), sheep (181-183) and mice (149). 
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The hypothalamic-pituitary-adrenal (HPA) axis is one pathway that is activated in 
response to stress. Stress initiates hypothalamic release of corticotropin-releasing 
hormone (CRH), which stimulates secretion of ACTH from pituitary and thereby 
increased glucocorticoid production by the adrenal cortex. Activation of the HPA axis as 
monitored by increased circulating glucocorticoids during the stress response commonly 
occurs concomitantly with inhibition of the reproductive system (119,184,185). Some 
studies, however, suggest that CRH could have a direct effect on reproduction 
independent of the downstream glucocorticoid pathway. Pretreatment with CRH 
receptor antagonists prevents stress-induced suppression of LH pulses (81,84,85). In 
addition, intracerebroventricular or median eminence administration of CRH inhibits LH 
pulses (81-83) and hypothalamic multiunit electrical activity (MUA) volleys that are 
associated with LH pulses (82). This inhibitory effect of CRH on LH pulses persists in 
adrenalectomized monkeys, which lack the main glucocorticoid production site.  
 
Interactions between the HPA axis and the reproductive system are modulated by 
estradiol. For example, estradiol potentiates inhibitory effects of insulin-induced 
hypoglycemia (77,111) and food deprivation (110) on LH pulses in ovariectomized 
(OVX) animals compared to those without estradiol treatment. OVX rats with estradiol 
replacement exhibit more severe suppression of LH secretion after CRH treatment than 
OVX rats (81). Further, estradiol treatment increases CRH receptor type-2 mRNA 
expression in immortalized GnRH neurons (GT1 cells) (116). These data indicate that 
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estradiol typically enhances the effect of stress on reproduction, potentially via a CRH-
mediated pathway. 
 
Anatomical observations suggest that CRH-producing neurons can directly affect GnRH 
neurons. CRH-containing fibers synapse on GnRH neurons (125,126). Approximately 
30% of GnRH neurons in female mice exhibit CRH receptor immunoreactivity (127). 
The antibody used did not distinguish between CRH receptor subtypes, however in the 
same paper, single-cell gene expression profiling was positive for CRHR-1 but not 
CRHR-2 (127). Intracerebroventricular injection of CRH decreases GnRH mRNA 
expression in ewes (186), and studies in GT1 cells suggest the inhibitory effect of CRH 
on GnRH mRNA expression could be direct (116). These lines of evidence suggest 
CRH may alter GnRH neuron function as one mechanism of altering the reproductive 
system. Here, we examined the effect of CRH on GnRH neuron activity, the type of 
receptors involved and the influence of estradiol milieu on this response in female mice. 
 
Materials and Methods 
All chemicals were purchased from Sigma Chemical Co. (St. Louis, MO, USA) unless 
otherwise noted.  
 
Animals  Female mice expressing GFP under the control of the GnRH promoter were 
used (187). Mice were on a B6CBA/F1 background and aged from 66 to 126 days. 
Animals were housed on a 14-h light, 10-h dark cycle with light on at 0400 AM EST. 
Animals were provided with water and Teklad 2916 chow (Envigo, Madison, Wisconsin, 
 25 
USA) ad libitum. To study effect of estradiol on stress response, mice were 
ovariectomized (OVX) under isoflurane anesthesia with bupivacaine as a local 
analgesic. Mice were either implanted with a Silastic (Dow Corning, Midland, MI, USA) 
capsule containing 0.625 μg of 17β-estradiol in sesame oil (OVX+E group) or not 
treated further (OVX) at the time of surgery (12). Recordings were performed 2-3 days 
after surgery. The Institutional Animal Care and Use Committee of the University of 
Michigan approved all procedures. 
 
Brain slice preparation Solutions were bubbled with 95% O2 and 5% CO2 throughout the 
experiments and for at least 15 min before exposure to tissues. The brain was removed 
rapidly 1.5 to 2h before lights off and placed in ice-cold sucrose saline solution 
containing 250 mM sucrose, 3.5 mM KCl, 26 mM NaHCO3, 10 mM D-glucose, 1.25 mM 
Na2HPO4, 1.2 mM MgSO4, and 3.8 mM MgCl2. Coronal brain slices (300 μm) were 
prepared with a Leica VT1200S (Leica Biosystems, Buffalo Grove, IL, USA). Slices 
were incubated in a 1:1 mixture solution of sucrose-saline and artificial cerebrospinal 
fluid (ACSF) containing 135 mM NaCl, 3.5 mM KCl, 26 mM NaHCO3, 10 mM D-glucose, 
1.25 mM Na2HPO4, 1.2 mM MgSO4, and 2.5 mM CaCl2 for 30 minutes at room 
temperature and then transferred to 100% ACSF for at least 30 minutes at room 
temperature before recording. Slices were placed in the chamber continuously perfused 
with oxygenated ACSF at a rate of 3 ml/min and heated by an in-line heater (Warner 
Instruments, Hamden, CT, USA) to maintain temperature at 30±1 °C. GFP-labeled 
GnRH neurons were identified by brief fluorescent illumination at 488 nm on an upright 
fluorescence microscope Olympus BX51W1 (Opelco, Dulles, VA, USA).  
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Electrophysiological recordings Recording pipettes were pulled from borosilicate 
capillary glass (type 7052, 1.65-mm outer diameter and 1.12-mm inner diameter; World 
Precision Instruments, Inc., Sarasota, FL, USA) using a Flaming/Brown P-97 (Sutter 
Instrument, Novato, CA, USA) to obtain pipettes with a resistance of 2 to 3.5 MΩ when 
filled with HEPES-buffered solution, containing 150 mM NaCl, 3.5 mM KCl, 10 mM 
HEPES, 10 mM glucose, 1.3 mM MgCl2, and 2.5 mM CaCl2. Targeted single-cell 
extracellular recordings were performed with an EPC-8 or EPC-10 dual-patch clamp 
amplifier (HEKA Elektronik, Holliston, MA, USA) and Patchmaster software (HEKA 
Elektronik) as data acquisition software. This method does not alter the intracellular 
milieu of the cell and minimizes interaction between the recording pipette and cell 
membrane (188,189). Low resistance seals were made between recording pipette and 
neuron. Seal resistance was checked every 10 minutes during the recording. Data were 
excluded if the resistance was >25 MΩ. Recordings were made in voltage-clamp mode 
at 0 mV holding potential and signal filtered at 10 kHz. Data were obtained from 9 to 12 
cells per treatment group, with no more than two cells per mouse; range of firing rate 
within an animal was similar to that between animals within a group. All recorded 
neurons were mapped to a brain atlas (190) to determine the relation between 
anatomical location and response to treatment. No correlation between location of cells 
and response was observed in this study. 
 
Experimental design GnRH neurons from OVX+E mice show time-of-day-dependent 
change in firing activity; the firing rate is low in the morning due to estradiol negative 
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feedback and high in the late afternoon due to estradiol positive feedback (12). To study 
effects of CRH on GnRH neuron firing activity, recordings were made in late afternoon 
when mice treated with estradiol exhibit positive feedback (12). After establishing the 
extracellular recording configuration, recordings were stabilized for 5-10 min and then 
spontaneous basal (control) activity was recorded for 5 min before treatment. CRH at 
various doses (0 (i.e., vehicle), 10, 30, 100 or 1000 nM; Bachem, Torrence, CA, USA) 
was then bath-applied for 5 min, followed by a wash period lasting up to 20 min to 
determine if effects were reversible. To study the CRH receptor (CRHR) subtypes that 
contribute to effects of CRH on GnRH neuron firing activity, specific agonists were used. 
The CRHR-1 agonist stressin I (10 nM; Bachem) or the CRHR-2 agonist urocortin III (10 
nM; Bachem) were bath-applied to separate sets of brain slices from OVX+E mice in 
place of CRH in the above paradigm. If no firing activity was observed during the wash 
out period, ACSF with 20 mM K+ was applied to induce firing to verify cell viability and 
recording integrity. If a cell did not display action currents in response to high K+ 
treatment, data from that cell were excluded from the analysis. All drug stocks (CRH, 
stressin I, urocortin III) were reconstituted in water and diluted at least 1:1000 in ACSF 
for treatments.  
 
Data analysis Action currents during targeted-extracellular recording reflect action 
potential firing. Action currents were detected using custom software written in Igor Pro 
(Wavemetrics, Lake Oswego, OR, USA). Data were binned at 60-s intervals and mean 
firing rate (number of action potentials/recording duration) was calculated for control 
(last 3 min of control period), treatment (last 2 min of treatment and first min of wash out 
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period; washout period begins when the intake is switched back to ACSF and treatment 
exposure continues unaltered for at least another minute before the solution change 
reaches the chamber), and wash out periods. The wash was divided into sequential 3-
min periods (skipping the first 2 min to allow solution exchange) to equalize the duration 
of recording for analysis. The first wash period in which mean frequency returned to 
baseline levels was used for analysis; the last wash period was used for cells in which 
firing rate did not completely recover from treatment. Percent change in mean firing 
frequency during treatment was calculated relative to that during the control period. 
Cells were defined as responding if firing frequency during treatment changed by ≥ 
30%; both responding and non-responding cells were included in statistical analyses for 
each treatment. In addition to mean firing rate, changes in burst firing characteristics of 
GnRH neuron were also determined. Groups of action currents (bursts) were identified 
by custom software in Igor Pro. This software adjusted the maximum time between 
events (burst window) from 0.01 to 5 s at 10 ms intervals. Events are included in a burst 
if the time interval between events is less than or equal to the burst window. For the 
present analyses, action currents were included together as a burst if the interval 
between events was ≤ 320 ms. This burst window was chosen because it provides the 
consistent maximum number of bursts detected by the software across the groups in 
this study. Burst frequency (bursts/3 min), burst duration, number of spikes/burst, and 
intraburst interval were analyzed and compared between control, treatment, and wash 
out periods.  
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Statistics Data are reported as mean±SEM. Statistical analyses were performed using 
Prism 7 (GraphPad Software, La Jolla, CA, USA). Normality of data was analyzed using 
a Shapiro-Wilk normality test. Two-way repeated-measure ANOVA was used to 
determine effects of CRH 30 and 100 nM on firing activity during control, treatment, and 
wash out periods of GnRH neurons between OVX and OVX+E mice. Student’s paired t 
test was used to analyze the effect of 1 µM CRH on GnRH neurons from OVX mice (no 
wash period was included for these recordings as the lack of effect was obvious). 
Effects of CRHR-specific agonists (stressin I and Ucn III) or vehicle on firing activity of 
GnRH neurons were analyzed by one-way repeated-measure ANOVA for control, 
treatment and wash out periods. Burst parameters as defined above were analyzed by 
two-way repeated-measure ANOVA for control, treatment, and wash out periods. 
Specific statistical tests are indicated in the figure legends. Significance was set at 
P<0.05. 
 
Results 
CRH does not affect GnRH neuron firing activity in OVX mice 
To study the effect of CRH on GnRH neurons in the absence of ovarian estradiol, we 
tested effects of low (30 nM) and high (100 nM) concentrations of CRH on GnRH 
neuron firing activity in brain slices from OVX mice. Figures 2-1A-C show representative 
traces from extracellular recording of GnRH neurons from OVX mice before and during 
treatment with CRH. A minority (2 of 9) of GnRH neurons from OVX mice treated with 
30 nM CRH exhibited increased firing by the 30% change criteria but overall this 
treatment had no effect on firing rate (Figure 2-1D, E, n=9 control 0.3±0.1 Hz, CRH 30 
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nM 0.4±0.1 Hz, wash 0.4±0.1 Hz, P>0.9). Similarly, in response to 100 nM CRH, 2 of 9 
GnRH neurons from OVX mice exhibited decreased firing, but overall 100 nM CRH had 
no effect on firing rate (Figure 2-1D, E, n=9 control 0.4±0.1 Hz, 100 nM CRH 0.4±0.2 
Hz, wash 0.5±0.1Hz, P>0.9). To examine if the lack of response in cells from OVX mice 
was due to insufficient dose, 1000 nM CRH was tested in this group; this dose had no 
effect on firing frequency of GnRH neurons from OVX mice (Figure 2-1D, E, n=5 control 
0.20±0.03 Hz, 1 µM CRH 0.20±0.03 Hz, P>0.8). 
 
CRH alters firing activity of GnRH neurons from OVX+E mice in dose-dependent 
manner 
To study if CRH affected GnRH neuron activity in the presence of estradiol, CRH was 
bath-applied to brain slices from OVX+E mice; no steroids were added during 
recordings, estradiol was present only in vivo. Representative traces of GnRH neuron 
firing activity during control, CRH treatment, and wash out periods are shown in Figures 
2A and B. In cells from OVX+E mice, 30 nM CRH increased the firing frequency in 4 of 
9 cells and increased overall firing rate of the group (Figure 2-2D, E, n=9, control 
0.7±0.1 Hz, CRH 30 nM 1.2±0.5 Hz, wash 0.7±0.2 Hz, P<0.05). In marked contrast, 100 
nM CRH decreased the firing frequency of 7 of 12 GnRH neurons from OVX+E mice 
(Figure 2-2D, E, n=12, control 0.8±0.2 Hz, CRH 100 nM 0.4±0.1 Hz, wash 0.8±0.2 Hz, 
P<0.01). During 100 nM CRH treatment, 2 of 12 cells showed increased in firing 
frequency, but the overall effect of 100 nM CRH was inhibitory. Because estradiol 
appeared to induce sensitivity of the GnRH firing response to CRH, we tried a lower 
CRH dose on slices from OVX+E mice. GnRH neurons did not respond to 10 nM CRH 
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treatment (n=5, control 0.4±0.2 Hz, CRH 10 nM 0.4±0.2 Hz, P>0.8). Similarly, vehicle 
treatment had no effect on GnRH neuron firing frequency (Figure 2-2D, E, n=5, control 
0.63±0.14 Hz, vehicle 0.56±0.12 Hz, P>0.1). These results suggest that CRH alters 
GnRH neuron activity in an estradiol-dependent manner with both stimulatory and 
inhibitory actions observed depending upon dose. Further, the consistent lack of 
response of cells from OVX mice to CRH and of OVX+E mice to 10 nM CRH or vehicle 
indicates that the changes attributed to 30 and 100 nM CRH in cells from OVX+E mice 
are not due to random fluctuations in firing rate of GnRH neurons (12,191). 
 
CRH stimulates GnRH neuron firing activity via CRHR-1 
Two types of CRH receptors have been identified in mammals: CRH receptor type-1 
and type-2 (CRHR-1 and CRHR-2) (43,192). CRHR-1 has a higher affinity for CRH 
(193). Thus, it is possible that low concentrations of CRH might activate mainly CRHR-1 
and lead to stimulation of GnRH neurons, whereas higher concentration of CRH could 
also bind and activate CRHR-2 and result in a different response. To test if CRH 
stimulates firing of GnRH neurons via CRHR-1, stressin I (CRHR-1 specific agonist) 
was bath-applied to brain slices from OVX+E mice and GnRH neuron firing activity 
recorded. Figure 2-3A shows representative traces from GnRH neurons in OVX+E 
before and during stressin I (10 nM) treatment. Stressin I increased firing rate of GnRH 
neurons in 7 of 11 cells from OVX+E mice and no cells exhibited decreased firing rate 
(Figure 2-3C, D, n=11, control 0.7±0.2 Hz, stressin I 1.0±0.2 Hz, wash 0.8±0.2 Hz, 
P<0.05). These data support the postulate that low concentrations of CRH activate 
GnRH neuron activity via the CRHR-1 pathway. 
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CRH inhibits GnRH neuron firing activity via CRHR-2 
To test if activation of CRHR-2 inhibits GnRH neurons, urocortin III (Ucn III), which has 
been described as an endogenous ligand specific for CRHR-2 (48), was bath-applied to 
brain slices from OVX+E mice. Ucn III (10 nM) suppressed firing frequency of GnRH 
neurons in 7 of 11 cells and no cells exhibited increased firing (Figure 2-3B-D, n=11, 
control 0.9±0.3 Hz, Ucn III 0.5±0.2 Hz, wash 0.9±0.3 Hz, P<0.05). This suggests that 
inhibitory effects of CRH on GnRH neuron activity are at least in part mediated through 
CRHR-2. 
 
Activation of CRH receptors alters short-term firing pattern of GnRH neurons 
The change in mean firing frequency provides an overview of the effects of CRH on 
GnRH neuron activity. The short-term pattern of how action currents are grouped 
together, referred to as burst firing, is also of interest and has been associated with 
hormone secretion from neuroendocrine cells (194). To further understand the effect of 
CRH on GnRH neurons, burst firing patterns of the above GnRH neurons from OVX and 
OVX+E mice were analyzed during control, CRH and CRH receptor agonist treatments, 
and wash out periods. All cells were analyzed for burst frequency in all three periods. Of 
61 cells studied, 59 cells exhibited bursts during all three periods and were included in 
the analysis of burst properties. One cell that exhibited bursts only during the control 
period, and one cell that exhibited bursts during control and treatment periods are 
shown in Figure 4 but not included in the repeated-measures analysis for burst 
properties as they had no bursts to analyze; these cells both fired single spikes 
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throughout the recording. Of note, two-group analysis of control vs. treatment and three-
group analysis of control, treatment and washout revealed statistical differences in the 
same parameters. In GnRH neurons from OVX mice, there was no change in any burst 
parameter analyzed in response to any treatment. In GnRH neurons from OVX+E mice, 
however, CRH (30 nM) and stressin I increased burst frequency (Figure 2-4A). In 
contrast, 100 nM CRH and Ucn III decreased burst frequency (Figure 2-4A). There was 
no change in burst duration, spikes/burst or intraburst interval after 100 nM CRH and 
UcnIII treatment (Figure 2-4B-D). CRH 30 nM increased both burst duration and 
spikes/burst (Figure 2-4C and 2-4D). Stressin I also decreased intraburst interval and 
mean burst duration in GnRH neurons (Figure 2-4B and 2-4C). Although the difference 
in intraburst interval caused by stressin I treatment achieved a P value indicating 
statistical significance, the absolute magnitude of the change is small and may have 
minimal biological effect. 
 
Discussion 
GnRH neurons integrate a variety of upstream inputs to produce a secretory output 
pattern that regulates the downstream reproductive system. Stress exposure can 
increase or decrease reproductive neuroendocrine output, and response to stress is 
also modulated by steroid milieu. Here we show that both stimulatory and inhibitory 
effects of stress can be induced by central interactions among neuroendocrine systems. 
Specifically, CRH can increase or decrease GnRH neuron firing rate; these effects are 
estradiol dependent and the differential response is mediated through activation of 
specific CRH receptors.  
 34 
CRH had a dose-dependent effect on firing rate of GnRH neurons from estradiol-treated 
OVX mice, with higher concentrations suppressing activity and lower concentrations 
stimulating it. The effects of CRH on GnRH neurons are mitigated in OVX mice, 
suggesting estradiol enables the mechanisms that mediate response to CRH. These 
findings support previous work demonstrating an effect of estradiol on the stress 
response and extend those studies to effects at the GnRH neuron. At the whole animal 
level, the inhibitory effect of stress or CRH treatment on LH pulse frequency is stronger 
in animals with elevated estradiol levels in several species, whether these are due to 
estradiol treatment or studies in the follicular vs luteal phase of the cycle 
(77,81,93,110,111,181,195). The mechanisms engaged by estradiol to facilitate the 
GnRH neuron response to stress are not known but several possibilities exist. First, 
estradiol may modulate CRH receptor expression. CRH receptor is higher during 
proestrus, when estradiol peaks during the cycle, than in diestrus (102). The CRHR-2 
promoter contains a classical estrogen receptor response element (104), which could 
be a target for regulation of expression. Although GnRH neurons lack estrogen receptor 
alpha (ER-a), both estrogen receptor beta (ER-b) and membrane estrogen receptors 
have been reported in GnRH neurons (134,196). It is thus possible that estradiol acts 
directly on GnRH neurons to alter CRH receptor expression in these cells. Second, 
estradiol alters ionic conductances in GnRH neurons, including voltage-gated potassium 
and calcium currents, transient receptor potential channels and hyperpolarization-
activated channels (197-202). In other neurons, CRH adjusts excitability by modulating 
multiple currents (203,204). Interactions between CRH actions and estradiol-induced 
changes in intrinsic properties of GnRH neurons could poise these cells to change firing 
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activity. Third, estradiol may facilitate GnRH neuron response by altering synaptic 
connectivity from afferent populations that are CRH-sensitive. Estradiol alters synaptic 
interactions in several brain regions, including the hypothalamus (205). Of interest in 
this regard, kisspeptin stimulation of GnRH neuron firing activity is greater in OVX+E 
than OVX mice because in the former kisspeptin increases excitatory neurotransmission 
to GnRH neurons, in addition to direct effects on GnRH neurons observed in both 
animal models (140,206). Fourth, estradiol increases CRH mRNA expression in the 
paraventricular nucleus (PVN) of the hypothalamus in rats (77). This does not apply to 
the design of the present study because CRH was applied as a treatment, but estradiol 
upregulation of CRH levels could enhance the effect of stress on reproductive system in 
vivo.  
The effects of CRH on GnRH neurons observed in this study could be direct and/or 
indirect. CRH-containing fibers synapse on GnRH neurons, which express CRH 
receptor type-1, enabling direct action (125-127). Fibers from CRH-producing neurons 
in the PVN appose GnRH neurons (125). The source of CRH that acts on GnRH 
neurons remains controversial, however, as retrograded tracing with cholera toxin from 
the preoptic area revealed only sparse overlap with CRH neurons in PVN (130). This 
very sparse PVN CRH input to GnRH neurons may be due to the relative 
underinnervation of GnRH neurons (1), because direct innervation of GnRH neurons by 
CRH arises from a different source, and/or because PVN CRH neurons act on GnRH 
neurons via intermediate cells. Indirectly, GnRH neurons receive numerous upstream 
inputs and integrate those signals to regulate the downstream reproductive system. 
Some of these inputs may be CRH-sensitive. GABA and glutamate fast synaptic 
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transmission are the main forms of communication in the brain (207,208) and GnRH 
neurons receive both types of fast synaptic inputs (157,209). Blocking GABAA receptors 
in the preoptic area in vivo eliminates the ability of CRH to reduce LH pulse frequency 
(162,163); because the action of GABA on GnRH neurons is excitatory (153) this 
suggests receptors on other cells exhibiting the more typical inhibitory response to 
GABA mediate this response. Stress modifies glutamatergic synapses in other brain 
regions (210). In addition to fast synaptic transmission, stress may affect 
neuromodulation of GnRH neurons. In this regard, both the stimulatory kisspeptin 
system (140,142,211), and inhibitory gonadotropin-inhibitory hormone (GnIH) system 
(166,167,212,213) are affected by stress. Kisspeptin neurons both in the arcuate and 
anteroventral periventricular nucleus regions are reported to express CRH receptors 
(150). Stress exposure or CRH treatment decrease Kiss1 and Kiss1r expression in the 
hypothalamus (65), possibly reducing excitatory neuromodulation of GnRH neurons via 
kisspeptin. Although only a small percent (13%) of GnIH neurons express CRH-R1 
receptors (171), over half of GnIH neurons have increased Fos expression in response 
to stress exposure (172); stress also increased the number of appositions from GnIH-
immunoreactive fibers on GnRH neurons (172). These changes would potentially 
enhance effects of this inhibitory system. Action of CRH via GnRH neuron afferents 
might explain why some GnRH neurons in this study did not respond to CRH treatment; 
specifically in some brain slices, upstream cells that are CRH-responsive might be 
removed during slice preparation.  
The dose dependency of the response to CRH suggested the possibility that different 
CRH receptors may mediate these responses. We used receptor-specific agonists to 
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test this and found that activation of CRHR-2 inhibits GnRH neurons, whereas CRHR-1 
stimulates GnRH neurons. The involvement of two receptors mediating opposite effects 
may explain some of the variation observed when CRH itself was used as a treatment. 
The primary effect of 100 nM CRH was inhibitory, but a couple of cells increased firing 
in response to this treatment; in contrast, none of GnRH neurons treated with the 
CRHR-2 specific agonist Ucn III, exhibited stimulation. CRH may activate both receptor 
subtypes and, in most cases, the inhibitory effects of CRH overpowered the stimulatory 
effect resulting in suppression of GnRH neuron activity. Similarly, when the specific 
CRHR-1 agonist was used, a higher percent of GnRH neurons responded than did to 30 
nM CRH and all responding cells increased firing rate.  
The receptor-specific effects of CRH on GnRH neuron firing may be attributable to 
signaling pathways engaged upon CRH agonist binding. CRH receptors are class-B G-
protein coupled receptors that can interact with several Ga subunits (214,215). CRHR-1 
appears to primarily couple to Gas and Gaq (216,217). CRHR-2, however, couples with 
multiple types of G-proteins, including Gaq (217,218), Gas (219), and Gai (217). The 
type of Ga subunit coupled to CRHR-2, and to some extent CRHR-1, varies among cell 
types (216). The simplest explanation for the opposite effects of activating CRHR-1 vs 
CRHR-2 would be direct action on GnRH neurons via Gas and Gai subunits. Beyond 
the current lack of evidence for CRHR-2 expression in GnRH neurons, this explanation 
does not take into account possible indirect action via afferents that excite or inhibit 
GnRH neurons. For example, activation of GnRH neuron firing by CRHR-1 agonists 
may be due to stimulation (via Gas or Gaq) of an excitatory input. Suppression of 
GnRH neurons by CRHR-2 agonists may be due to suppression (via Gai) of an 
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excitatory input or activation (via Gas and Gaq) of an inhibitory input. Future work to 
determine the cell signaling pathways in GnRH neurons and their upstream regulators 
upon activation of CRHRs are needed to test these postulates. 
The ability of CRH to both activate and inhibit GnRH neurons could contribute to the 
different response of the reproductive system to stress. The importance of CRHR-2 in 
inhibitory effects of stress on fertility has been noted in several studies (85,86,116). 
Pretreatment with a CRHR-2 antagonist prevents stress-induced suppression of LH 
pulses by metabolic (insulin-induced hypoglycemia), immunological 
(lipopolysaccharide), and psychological (restraint) stressors (85). Urocortin II (Ucn II), 
which exhibits high affinity for CRHR-2 and low affinity for CRHR-1 similar to Ucn III 
(48,220), suppresses LH pulses in female rats in a dose-dependent manner and 
blocking of CRHR-2 abolishes the effect of Ucn II on LH pulses (86). Interestingly, 
expression of mRNA encoding Ucn II in the PVN is increased following restraint stress 
(221). A role for CRHR-1 in stimulatory effect of stress on reproductive system in vivo 
has also been reported. Exposure to restraint stress on the morning of proestrus 
induces LH and FSH secretion in female proestrous rats (90). This stimulatory effect of 
restraint stress on LH secretion is blocked by pretreatment of CRHR-1, but not CRHR-2, 
antagonist suggesting CRHR-1 mediates the stimulatory effect of stress. The present 
results support and extend these previous findings by demonstrating that activation of 
CRHR-1 vs CRHR-2 can induce or suppress firing of GnRH neurons, respectively.  
Burst firing in neuroendocrine cells is related to the secretion of hormones 
(194,222,223). GnRH neurons exhibit burst firing pattern, although the burst firing in 
GnRH neurons is slower (224,225) compared to other neurons (226-228). Treatments 
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that inhibited mean firing rate of GnRH neurons (100 nM CRH or Ucn III) did so by 
reducing the number of bursts; once initiated, burst duration, number of spikes per 
burst, and intraburst interval were not different. This may suggest CRHR-2 agonists act 
indirectly to reduce excitatory drive to GnRH neurons. This would decrease initiation of 
action potentials and hence number of bursts, but once the burst is initiated, burst 
characteristics would remain similar because intrinsic properties of GnRH neurons are 
unaffected. In contrast to CRHR-2, activation of CRHR-1 by 30 nM CRH or stressin I 
increased burst firing in GnRH neurons. Further, these treatments altered other burst 
parameters. This suggests a possible direct action via CRHR-1 on GnRH neurons to 
change intrinsic properties and burst characteristics. Consistent with these postulates 
and as mentioned above, CRH receptor type 1 mRNA, but not type 2, appears to be 
expressed in GnRH neurons from female mice (127). Although CRH did not alter mean 
firing frequency of GnRH neurons from OVX mice, it is possible to alter burst firing 
without affecting the overall frequency, but we did not observe any change in burst 
parameters in GnRH neurons from OVX mice during either 30 nM or 100 nM CRH 
treatments. This emphasizes the importance of estradiol in the response of GnRH 
neurons to CRH.  
The relationship between stress and reproduction varies among studies. The present 
findings that CRH exerts either stimulatory or inhibitory effects on GnRH neuron activity 
depending on the CRH receptor activated provide mechanistic insight into how stress 
can have different effects. The finding that estradiol potentiates both effects of CRH on 
GnRH neurons supports and extends previous work indicating steroid milieu alters the 
response to stress. Together, these observations indicate interactions among the stress 
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and reproductive axes are bidirectional. These findings can help shape future studies of 
the mechanisms that underlying the difference responses resulting from stress 
exposure in animals
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Figures and Legends 
 
 
 
   
Figure 2-1. CRH has no effect on the firing rate of GnRH neurons from OVX mice. A-C, 
representative raw data from extracellular recordings of GnRH neurons during each 
period for 30 nM (A) 100 nM (B) and 1000 nM (C).  D, firing rate of individual GnRH 
neurons during control (C), CRH treatment (CRH30, CRH100, or CRH1000), and wash 
out (W) periods. Green and red lines indicate cells with ≥30% increase or decrease in 
firing frequency during treatment, respectively. E, Mean±SEM percentage of control 
firing frequency. Green and red lines indicate cells with ≥30% increase or decrease in 
firing frequency during treatment, respectively. No differences were detected for either 
firing frequency (P>0.5, two-way repeated-measures ANOVA/Tukey (30, 100 nM) or 
paired Student’s t test (1000nM), or % of control frequency (P>0.1, Friedman 
test/Dunn’s post-hoc or paired Student’s t test). 
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Figure 2-2. CRH has dose-dependent effects on firing activity of GnRH neurons from 
OVX+E mice. A-C, representative raw data from extracellular recordings of GnRH 
neurons during each period. D, firing rate of individual GnRH neurons during control (C), 
CRH treatment (CRH30 or CRH100) or vehicle treatment (Veh), and wash out (W) 
periods. Green and red lines indicate cells with ≥30% increase or decrease in firing 
frequency during treatment, respectively. *, P<0.05 mean firing frequency compared to 
control period, two-way repeated-measures ANOVA/Tukey. E, Mean±SEM percentage 
of control firing frequency. #, P<0.05 compared to control period, Friedman test/Dunn’s 
post-hoc.   
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Figure 2-3. Activation of specific CRH receptors has different effects on GnRH neuron 
firing activity. A and B, representative raw data from extracellular recordings of GnRH 
neurons during control (left) and CRH receptor agonist treatment periods (stressin 1, top 
right; ucn III bottom right). C, firing frequency of individual GnRH neurons during control 
(C), treatment (Str: stressin I or Ucn3: Ucn III), and wash out (W) periods. Green and 
red lines indicate cells with 30% increase or decrease in firing frequency during 
treatment, respectively. *, P<0.05 mean firing frequency compared with control period, 
two-way repeated-measure ANOVA/Tukey. D, Mean±SEM percentage of control firing 
frequency. #, P<0.05 compared with control period, Friedman test/Dunn’s. 
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Figure 2-4. CRH alters GnRH neuron burst firing pattern in OVX+E mice. A. Burst 
frequency of individual GnRH neurons during the control, treatment and wash periods 
analyzed in Figures 1-3. B-D Intraburst interval (B), burst duration (C) and spikes/burst 
(D) of individual GnRH neurons. Values from the same cell are connected by lines. 
Mean ± SEM are shown as a circle with error bar in A-D. Triangles in B-D indicate 
control burst parameter values of a cell in the C30 group that had bursts during the 
control period but not during CRH treatment (grey line in A). Dashed lines in A-D 
connect control and treatment burst parameters of a cell in the C30 group that exhibited 
bursts during the control and treatment periods but only single spikes during the wash 
period. C30, 30 nM CRH; C100, 100 nM CRH; Str, stressin I; UcnIII, urocortin III; *, 
P<0.05 control vs treatment, two-way repeated-measure ANOVA/Tukey for CRH 
treatments and Friedman test/Dunn’s for stressin I and UcnIII.
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Chapter 3: Neurobiological Mechanisms Underlying the Effects of Corticotropin-
releasing Hormone (CRH) on Gonadotropin-releasing Hormone (GnRH) Neuron 
Function 
 
Abstract 
GnRH neurons are central regulators of reproduction and respond to factors affecting 
fertility, such as stress. Corticotropin-releasing hormone (CRH) is released during stress 
response. In brain slices from unstressed controls, CRH has opposite, estradiol-
dependent, effects on GnRH neuron firing depending on the CRH receptor activated; 
activating CRHR-1 stimulates whereas activating CRHR-2 suppresses activity. We 
investigated possible direct and indirect mechanisms. Mice were ovariectomized and 
either not treated further (OVX) or given a capsule producing high positive feedback 
(OVX+E) or low negative feedback (OVX+low E) physiologic circulating estradiol levels. 
We tested possible direct effects on GnRH neurons by altering voltage-gated potassium 
currents. Two types of voltage-gated potassium currents (transient IA and sustained IK) 
were measured; neither CRHR-1 nor CRHR-2 agonists altered potassium current 
density in GnRH neurons from OVX+E mice. Further, neither CRH nor receptor-specific 
agonists altered action potential generation in response to current injection in GnRH 
neurons from OVX+E mice. To test the possible indirect actions, GABAergic 
postsynaptic currents were monitored. A CRHR-1 agonist increased GABAergic 
transmission frequency to GnRH neurons from OVX+E, but not OVX, mice, whereas, a 
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CRHR-2 agonist had no effect. Finally, we tested if CRH alters the firing rate of arcuate 
kisspeptin neurons, which provide an important excitatory neuromodulatory input to 
GnRH neurons. CRH did not acutely alter firing activity of these neurons from OVX, 
OVX+E or OVX+low E mice. These results suggest CRH increases GnRH neuron 
activity in an estradiol-dependent manner in part by activating GABAergic afferents. 
Mechanisms underlying inhibitory effects of CRH remain unknown. 
 
Introduction 
Gonadotropin-releasing hormone (GnRH) neurons are the central output components of 
the hypothalamo-pituitary-gonadal (HPG) axis. GnRH is released in a pulsatile manner 
that stimulates the anterior pituitary to secrete luteinizing hormone (LH) and follicle-
stimulating hormone, which control steroidogenesis and gametogenesis. GnRH neurons 
integrate several inputs that regulate their activity, hormone release and thus 
reproductive function. One such signal is stress. Most research indicates stress inhibits 
reproductive parameters, such as LH and/or GnRH pulses, multiunit activity (MUA) 
associated with LH release, reproductive cycles, and the preovulatory LH surge that 
triggers ovulation (70,93,229-235). There are several examples, however, where stress 
can activate aspects of the reproductive system in an acute manner 
(114,115,177,236,237). Further, sex steroid milieu sculpts the response of the 
reproductive system to stress, suggesting bidirectional interactions of these systems 
(77,81,111). Circulating estradiol, in particular, appears to potentiate the effects of 
stress (77,81,111). 
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Stress activates several pathways, including the hypothalamic-pituitary-adrenal (HPA) 
axis, triggering release of corticotropin-releasing hormone (CRH, also known as 
corticotropin-releasing factor, CRF). CRH may mediate inhibitory effects of stress on 
reproduction. Pretreatment with individual or combined CRH receptor antagonists 
blocks effects of different stressors on LH pulses (85,86), and intracerebroventricular 
injection of CRH suppresses LH pulses (a bio-readout of GnRH pulses) (237). In some 
instances, however, CRH can acutely activate the reproductive system. For example, 
central injection of CRH increases LH pulse frequency in both male and female 
gonadectomized sheep supplemented with estradiol (88). One third of ovariectomized 
monkeys injected with CRH exhibited premature, short-duration hypothalamic multiunit 
activity volley (237), indicating central stimulatory effects of CRH.  
 
To examine how stress interacts mechanistically with the neuroendocrine control of 
reproduction, we focused on its effects on estradiol positive feedback induction of the 
LH surge. Exposure to a layered, psychosocial stress paradigm on the morning of 
proestrus disrupted the LH surge in about two-thirds of mice (119). Interestingly, uterine 
mass in these mice was indistinguishable from animals that exhibited LH surges. 
Because uterine mass is linearly correlated with estradiol levels (120), this suggested a 
failure to process rather than a failure to generate the estradiol rise. Consistent with this, 
the same layered stress paradigm disrupted the estradiol-induced LH surge using an 
established daily LH surge model (119). Using this same daily surge model in 
unstressed mice, CRH was shown to stimulate or inhibit the firing activity of GnRH 
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neurons depending on the type of CRH receptor (CRHR) activated; these effects were 
dependent upon circulating estradiol (238).  
 
Here we extended these studies to examine the neurobiological mechanisms underlying 
the stimulatory and inhibitory effects of activation of CRHR on GnRH neuron firing rate. 
We examined potential direct effects via voltage-gated potassium currents in GnRH 
neurons and the excitability of these cells, and potential indirect mechanisms via 
GABAergic and arcuate kisspeptin-neurokinin B-dynorphin (KNDy) afferents. We further 
examined if circulating estradiol modulates the effects of CRH receptor activation on the 
afferent populations studied. 
 
Materials and Methods 
All chemicals were purchased from Sigma-Aldrich (St. Louis, MO, USA) unless 
otherwise noted. 
 
Animals The Institutional Animal Care and Use Committees of the University of 
Michigan or the University at Albany approved all procedures. Mice aged from 62 to 120 
d were used for all experiments. No correlation between the age of animals and the 
response to treatment was observed in any study. Adult transgenic female mice 
expressing green fluorescent protein (GFP) under the control of GnRH promoter 
(GnRH-GFP, JAX 033639) or eGFP under control of the Tac2 promoter (Tac2-GFP, 
015495-UCD/STOCK Tg [Tac2-EGFP]381 Gsat) were used for electrophysiology. Tac2 
encodes tachykinin 2, which is a precursor for neurokinin-B. Single-cell PCR 
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demonstrates that fluorescently-identified cells in the relatively thick brain slices used for 
recording in the Tac-2-GFP mouse model also express kisspeptin and/or dynorphin at 
high percentages in support of their identity as KNDy neurons (239). These mice were 
housed in the University of Michigan vivarium on a 14 h light and 10 h dark cycle with 
lights on at 04:00 AM Eastern Standard Time and were provided with water and Teklad 
2916 chow (Envigo, Madison, WI) ad libitum. A transgenic CRHR-1 reporter line in 
which a bacterial artificial chromosome containing the CRHR-1 promoter was used to 
drive GFP expression was also used (CRHR-1-GFP; (240)). These mice were 
maintained in the University at Albany vivarium under 12 h light and 12 h dark cycle with 
lights on at 07:00 AM Eastern Standard Time, with and were provided with Prolab 
Isopro RMH 3000 (5P76) chow (Purina, St. Louis, MO) and water available ad libitum.  
 
To study the influence of circulating estradiol on responses to CRH and specific 
receptor agonists, two different steroid feedback models were used. First, an 
established daily surge model that produces diurnal shifts between estradiol negative 
feedback in the AM and positive feedback in the PM was used, with mice studied in the 
PM during positive feedback (119,139,157,199,238,239,241-244). For this, mice were 
ovariectomized (OVX) under isoflurane anesthesia with bupivacaine as a local 
analgesic 2-3 d before the day of experiment. At the time of surgery, mice were either 
implanted with a Silastic capsule (0.078” I.D. x 0.125” O.D., Dow Corning, Midland, MI) 
containing 0.625 µg of estradiol in sesame oil (OVX+E) or not treated further (OVX) 
(12,245). In this daily surge model, uterine mass is higher in OVX+E than OVX mice, 
indicating a difference in functional circulating estradiol levels (GnRH-GFP OVX 
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45.9±2.8 mg, OVX+E 175.2±2.0 mg, p<0.0001 two-tailed Mann-Whitney U test, U=0; 
Tac2-GFP OVX 41.9±1.6 mg, OVX+E 136.8±4.7 mg, p<0.0001 two-tailed Mann-
Whitney U test, U=0;). Mice used for assessment of CRHR-1 co-labeling with GnRH 
were implanted with the 0.625 µg estradiol capsules. Second, for some studies 
(explained below) we adopted a new model that produces negative feedback with 
exposure to a lower level of estradiol (low E) (117). Mice were OVX+low E using the 
same procedures, but the implant contained 107 ng estradiol and mice were studied 10-
12 days after surgery. Uterine mass from the groups prepared in in this model indicate 
level of estradiol replacement consistent with diestrus, and a further reduction in uterine 
mass in OVX mice attributable to longer duration post OVX compared to the daily surge 
model above (n=5 each, OVX 19.8±0.7 mg, OVX+low E 39.2±0.8 mg, p=0.0079 two-
tailed Mann-Whitney U test, U=0). 
 
Experimental design overview  The daily LH surge model of estradiol positive feedback 
(119,139,157,199,238,239,241-244) was used for most studies to examine the 
neurobiological mechanisms induced by activation of CRH receptors. This model 
exhibits similar neurophysiologic measures to those that occur in GnRH neurons on 
proestrus (12,243,246). Because effects of CRH and receptor-specific agonists were 
dependent on circulating estradiol in past work, studies of GnRH neurons were done in 
OVX+E mice, with OVX mice examined to test for estradiol dependence if the 
parameter being monitored was altered in response to acute drug treatment. Both OVX 
and OVX+E mice prepared in the daily surge model were included in studies of Tac2-
GFP neurons to test for estradiol dependence of acute actions of CRH. The low E 
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model was used to test if the lack of suppressive effect of CRH on Tac2-GFP neurons 
was because the strong suppressive effect of the daily surge estradiol dose precluded 
observation of an acute inhibition of activity by treatment. The low E model mimics 
diestrous uterine mass, diurnal corticosterone patterns and reduces LH pulse frequency 
(117).  
 
For electrophysiology studies, we focused on females as the effects of stress on fertility 
are more pronounced; male mice were also included for the immunofluorescence study. 
The desired recording configuration was achieved, recordings stabilized as specified for 
each approach, then control measures obtained (vehicle for all treatments was ACSF). 
Treatment was bath-applied for 5 min. Analysis of treatment effects began 3 min after 
treatment was initiated (1 min to reach bath and 2 min for solution exchange). This was 
the time required to observe differences in firing rate in response to CRH or CRHR 
agonists (238). Treatment was washed out and reversibility assessed 5-15 min after 
wash began. To probe the mechanisms underlying activation of CRHR-1 (aka CRF1R) 
vs CRHR-2 (aka CRF2R), receptor-specific agonists were chosen. This allowed parallel 
studies with drugs at an effective dose (10 nM) that exhibited at least 100 fold selectivity 
for that receptor (48,247). The concentration of was selected based on the literature and 
was effective in previous studies demonstrating changes in firing activity of GnRH 
neurons (238) and reconfirmed here to test preparation effectiveness. The CRHR-1 
agonist stressin I (10 nM, Tocris) increased GnRH neuron firing (n=6, con 0.34±0.07 Hz, 
stressin I 0.63±0.17 Hz, P=0.03 two-tailed, Wilcoxon signed rank test, W=21); the 
CRHR-2 agonist urocortin 3 (10 nM, Bachem, Torrance, CA) decreased GnRH neuron 
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firing (n=6, con 0.54±0.31 Hz, urocortin 3 0.07±0.02 Hz, P=0.03, two-tailed Wilcoxon 
signed rank test, W=-21). 
 
Brain slice preparation  All solutions were bubbled with 95% O2 and 5% CO2 for at least 
15 min before exposure to tissue and throughout the experiments. Brains were rapidly 
removed 11.5-12 h after lights on and placed in an ice-cold sucrose saline solution 
containing (in mM): 250 sucrose, 3.5 KCl, 25 NaHCO3, 10 D-glucose, 1.25 Na2HPO4, 
1.2 MgSO4, and 3.8 MgCl2. Coronal slides (300 µm) were made with a Leica VT1200S 
(Leica Biosystems, Buffalo Grove, IL). Slices were incubated in a 1:1 mixture of 
sucrose-saline and artificial cerebrospinal fluid (ACSF) containing (in mM): 135 NaCl, 
3.5 KCl, 26 NaHCO3, 10 D-glucose, 1.25 Na2HPO4, 1.2 MgSO4, 2.5 CaCl2 for 30 min at 
room temperature. Slices were then transferred to 100% ACSF at room temperature for 
at least 30 min before recording. Slices were used within 6 h of preparation. No more 
than two cells were used per animal and n is defined as number of cells. 
 
Electrophysiology recordings  Brain slices were transferred to a recording chamber and 
perfused with oxygenated ACSF at a rate of 3 mL/min and heated by an in-line heater 
(Warner Instruments, Hamden, CT) to maintain temperature at 30±1°C. GFP-positive 
neurons were identified by brief illumination with 470 nm light using an upright 
fluorescence microscope Olympus BX51W1 (Opelco, Dulles, VA). Recording pipettes 
were pulled from borosilicate glass pipettes (type 7052, 1.65 mm outer diameter and 
1.12 mm inner diameter; World Precision Instruments, Inc., Sarasota, FL) using a P-97 
puller (Sutter Instruments, Novato, CA) to obtain pipettes with a resistance of 2 to 3.5 
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MW. All recordings were performed with an EPC-10 dual-patch clamp amplifier and 
Patchmaster acquisition software (HEKA Elektronik, Holliston, MA). The membrane 
potential for recordings with 20 or 140 mM chloride pipette solutions were corrected on-
line for liquid junction potentials of -14.7 mV and -4.9 mV, respectively. All recorded 
cells were mapped to a brain atlas (248) to determine whether cell location is related to 
response to treatment. No correlation between location and response was observed in 
this study. Whole-cell recording quality was monitored by assessing input resistance 
(Rin), series resistance (Rs), capacitance (Cm) and holding current (Ihold) every 3 min 
from the average of 20 traces recorded in response to a 20 ms 5 mV hyperpolarizing 
step. Only recordings with stable (<20 % change) Rin (>500 MW), series resistance 
(<20 MW), Cm (10-35 pF) and Ihold (-60 to 5 pA) were analyzed. 
 
Voltage-gated potassium currents  To isolate voltage-gated potassium currents, brain 
slices were perfused with ACSF supplemented with 2 µM tetrodotoxin (TTX; Tocris), 
200 µM CdCl2, 20 µM D-APV (Tocris), 10 µM CNQX, and 100 µM picrotoxin to block 
fast sodium and calcium currents, and ionotropic GABA and glutamate receptors. GnRH 
neurons from OVX+E mice were recorded in whole-cell voltage-clamp mode and held at 
-60 mV between voltage protocols. The current density of two types of voltage-gated 
potassium currents, the rapid (IA) and the sustained (IK), were recorded using 
abbreviated protocols to minimize drift between control and treatment periods. To 
record total potassium current, membrane potential was hyperpolarized (500 ms at -110 
mV) to remove inactivation of the rapid component followed by a 500 ms prepulse of -
110 mV and then the current measured at the test step (250 ms at -10 mV). To record 
 54 
the sustained current, a depolarized prepulse (500 ms at -40 mV) was applied to 
inactivate the transient current leaving only sustained current to be recorded during the 
50 ms test pulse at -10 mV. All traces were on-line leak subtracted using a P/-4 
protocol. To test effects of activating CRH receptor subtypes on voltage-gated 
potassium currents, IA and IK were compared between control and treatment periods. 
After a 2-min stabilization period, the voltage-gated potassium current protocol was 
performed five times at 30-s intervals under control conditions, then 10 nM of either 
stressin I (CRHR-1 agonist; Tocris) or urocortin 3 (CRHR-2 agonist; Bachem, Torrance, 
CA) starting 3 min after treatment initiation. 
 
Excitability in GnRH neurons  Whole-cell current-clamp recordings were performed on 
GnRH neurons from OVX+E mice in the presence of 20 µM D-APV, 10 µM CNQX, and 
100 µM picrotoxin to block ionotropic GABA and glutamate receptors. After achieving 
stable whole-cell recordings and adjusting bridge balance (95%), direct current (<25 pA, 
10.1±1.2 pA) was adjusted to keep the membrane potentials within 2 mV of -70 mV. 
Membrane response of GnRH neurons was then recorded in response to current 
injections (0 to 40 pA, 2 pA intervals, 500 ms). This protocol was run three times 
separated by 1 min during the control period and then treatment (100 nM CRH, 10 nM 
stressin I, or 10 nM urocortin 3) was bath-applied for 5 min and the protocol run again 
three times starting 3 min after treatment initiation, then treatment was washed out for 
5-10 min and the protocol repeated three more times. The number of action potentials 
at each current step was averaged and compared among control, treatment, and wash 
out periods. The first spike fired was used to determine action potential properties: 
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minimum current needed to induce firing (rheobase), latency from start of the current 
injection to first spike, firing threshold (defined as 1 V/s), rate of rise, peak amplitude 
relative to threshold, full-width at half-maximum (fwhm), and time, minimum, and 
amplitude of the afterhyperpolarization potential (AHP) relative to action potential 
initiation. 
 
GABAergic postsynaptic currents (PSCs)  Whole-cell voltage-clamp recordings were 
made of GABA PSCs in GnRH neurons held at -65 mV in brain slices from OVX+E and 
OVX mice. High-resistance seals (≥1.5 GΩ) were made between the pipette tip and cell 
membrane. Pipettes were filled with a solution containing (in mM): 140 KCl, 10 HEPES, 
5 EGTA, 0.1 CaCl2, 4 MgATP, and 0.4 NaGTP, and recordings were done in the 
presence of 10 µM CNQX and 20 µM D-APV to block ionotropic glutamatergic 
receptors. After establishing the whole-cell recording configuration, recordings were 
stabilized for 3 min and then were recorded for a 6-min control period (2x3 min). The 
CRHR-1 agonist stressin I (10 nM) or the CRHR-2 agonist urocortin 3 (10 nM) were 
bath-applied for 5 min to brain slices. Data were continuously recorded, but analysis of 
treatment effects began 3 min after treatment initiation. This was followed by a wash 
period lasting up to 15 min to determine if any effects were reversible.  
 
Extracellular recordings  Targeted extracellular recordings were performed to determine 
the effect of CRH on firing rate of KNDy neurons. Recording pipettes were filled with 
HEPES-buffered solution, containing (in mM): 150 NaCl, 3.5 KCl, 10 HEPES, 10 D-
glucose, 1.3 MgCl2, and 2.5 CaCl2. Low resistance seals (<25 MW) were made between 
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the recording pipette and neuron. After establishing the extracellular recording 
configuration, recordings were stabilized for 5-10 min. Basal activity of KNDy neurons 
from OVX and OVX+E mice were recorded for a 5-min control period, followed by bath-
application of 100 nM CRH for 5 min. Data were continuously recorded, but analysis of 
treatment effects began 3 min after treatment initiation. This was followed by a wash 
period of up to 15 min. If no firing activity was observed during the wash period, ACSF 
with 20 mM K+ was applied to induce firing to verify cell viability and recording integrity. 
If a cell did not display action currents in response to high K+ treatment, data from that 
cell were excluded from the analysis. Recordings of the same duration were also 
conducted with vehicle to examine stability of firing rate over time since initiation of the 
recording. 
 
Data analysis  Events (PSCs or action currents) were detected using custom software 
written in Igor Pro (Wavemetrics, Lake Oswego, OR, USA). Data were binned at 60-s 
intervals and mean firing rate (number of action currents/recording duration) or mean 
PSC frequency (number of PSCs/recording duration) were determined for control (last 3 
min of control period), treatment (last 2 min of treatment and first min of wash out period 
when treatment is still present in the slice chamber), and wash out periods (last 3 min of 
wash out period). Percent changes in mean firing frequency or mean PSC frequency 
were calculated relative to that during the control period. Cells were defined as 
responding if the percent change is ≥30%, but both responding and non-responding 
cells were included in statistical analyses for each treatment. In addition to frequency, 
PSCs amplitude, decay time, and full width at half-maximum (fwhm) were analyzed. For 
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voltage-gated potassium currents, peaks of IA and IK were determined by customized 
software written in Igor Pro. IA was isolated by subtracting the sustained current 
recorded after the -40 mV prepulse from the total current. Current density was 
calculated by dividing peak current values by capacitance.  
 
GnRH/CRHR-1-GFP Tissue Processing, Immunofluorescence (IF), Microscopy, and 
Quantification  Dual-label fluorescent IHC was performed to determine if GnRH neurons 
co-express CRHR-1. Brains were collected from male, diestrous female, and OVX+E 2 
days post surgery CRHR-1-GFP mice (n=2/group) and stored in 4% paraformaldehyde. 
Twenty-four hours later, brains were moved to a 30% sucrose solution in which they 
were stored until cryostat sectioning at 30 µm into four series. For IF, brain sections 
were rinsed in phosphate-buffered saline (PBS; pH 7.6), and then placed in a blocking 
solution consisting of 4% normal donkey serum (4% NDS, Equitech-Bio, Kerryville, TX, 
USA) with 0.3% Triton-X in PBS (PBS-TX) for 1 h. Sections were then moved to primary 
antisera for GnRH (EL14; anti-rabbit; kindly provided by Oline Rønnekleiv; RRID: 
AB_2715535 (249); 1:5000 in block solution) and incubated overnight at room 
temperature. The following day, sections were rinsed in PBS and incubated in 
secondary antisera (Jackson ImmunoResearch, West Grove PA); donkey anti-rabbit 
Alexa 594; 1:500) for 2.5 h. Sections were then placed into the second primary antisera 
against GFP (Abcam; chicken; RRID: AB300798; 1:2000) at room temperature 
overnight. The next day, tissue was rinsed in PBS, and placed in secondary antisera 
(Jackson ImmunoResearch; donkey anti-chicken Alexa 488; 1:1500) for 2.5 h. After 
rinsing, sections were mounted and coverslipped with Vectashield HardSet mounting 
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media (Vector Labs, Burlingame, CA). Imaging of GnRH and CRHR-1-GFP was 
performed on a Nikon 80i microscope at 20X magnification. Images were collected from 
12 sections ranging from plate image 44 to 61 from the Allen Institute mouse brain 
coronal reference atlas (https://mouse.brain-map.org/static/atlas). The distance between 
sections that were quantified was 240 µm. Total numbers of GnRH neurons and 
GnRH/CRHR-1-GFP co-labeled neurons were counted bilaterally in these sections.  
 
Statistics  Data are reported as mean±SEM. Statistical analyses were performed using 
Prism 8 (GraphPad Software, La Jolla, CA, USA). Distribution of data was analyzed 
using a Shapiro-Wilk test. Details on specific tests are provided in the results. 
Significance was set at P<0.05. 
 
Results 
Activating CRH receptors does not affect the amplitude of voltage-gated 
potassium currents in GnRH neurons from OVX+E mice prepared in the daily 
surge model 
Firing rate of GnRH neurons from OVX+E mice is increased by activation of CRHR-1 
and decreased by activation of CRHR-2 (238). To test if CRH receptor activation 
modifies voltage-gated potassium currents in GnRH neurons to bring about these 
responses, the density of fast transient and sustained potassium currents in GnRH 
neurons from OVX+E mice was monitored before and during treatment of CRHR-
specific agonists. Representative traces are shown in Figures 3-1A and 3-1B. Neither 
the CRHR-1 agonist stressin 1 (10 nM) nor the CRHR-2 agonist urocortin 3 (10 nM) 
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altered either IA or IK current density in GnRH neurons from OVX+E mice (Figure 3-1C-
D, Table 3-1, both n=7, two-tailed, paired Student’s t test, P>0.1). Passive properties of 
GnRH neurons were not affected by either stressin I or urocortin 3 (Table 3-1). 
 
Neither CRH nor receptor-specific agonists alter excitability of GnRH neurons 
from OVX+E mice prepared in the daily surge model 
To investigate if CRH more broadly alters the excitability of GnRH neurons, we 
measured the response of GnRH neurons from OVX+E mice to current injection steps 
in whole-cell current-clamp recordings. Figure 3-2A shows representative responses to 
16 and 24 pA injections. The number of spikes generated in response to current 
injections from GnRH neurons were not altered by CRH (100 nM, n=7) treatment 
(Figure 3-2B, Table 3-2). Other action potential parameters were also not affected by 
CRH treatment (Figure 3-2C-J, Table 3-2). We further tested effects of specific CRHR 
agonists. Selective activation of CRHR-1 (10 nM stressin I, n=7) did not affect 
excitability of GnRH neurons or action potential properties (Figure 3-3, Table 3-2). 
Likewise, the excitability of GnRH neurons was not affected by selective activation of 
CRHR-2 (10 nM urocortin 3, n=8, Figure 3-4). Of note, 3 of 8 of GnRH neurons (green 
lines Figure 3-4C) showed an apparent increase in excitability during urocortin 3 
treatment. Other parameters (AP width, amplitude, threshold, rate of rise, AHP 
amplitude, AHP time, and AHP minimum) were not affected by urocortin 3 treatment 
(Figure 3-4D-J, Table 3-2). Neither CRH nor CRHR agonists affected passive properties 
of GnRH neurons (Table 3-3). These results indicate that activation of CRH receptors 
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has no acute effect on the ability of GnRH neurons to generate action potentials in 
response to current injection.  
 
No colocalization observed between CRHR-1 and GnRH in either females or 
males 
Of a total of 156 GnRH neurons counted from two diestrous females (Figure 3-5A-D) 
and 117 GnRH neurons counted from two males (Figure 3-5E-H), and 153 counted from 
two OVX+E females (Figure 3-5I-L), none were found that were co-labeled with CRHR-
1-GFP. CRHR-1-GFP neurons were, however, often found in proximity to GnRH 
neurons. Mice for the immunofluorescent work were housed under a 12:12 light:dark 
cycle vs 14:10 for electrophysiology, and these mice were gonad intact. It is possible 
either of these changes could alter receptor expression, however the lack of detectable 
CRHR-1 within GnRH neurons in both males and females is consistent with the above 
physiologic studies indicating no effects of stressin I on GnRH neuron intrinsic 
properties that were examined. 
 
CRH does not acutely alter firing rate of Tac2-GFP-identified cells prepared in the 
daily surge model 
Because arcuate kisspeptin neurons are important upstream regulators of GnRH 
neurons that have been implicated in the stress response, we next tested if CRH affects 
the firing rate of Tac2-GFP neurons in this region in brain slices from OVX and OVX+E 
mice. Figures 3-6A and 3-6B show representative extracellular recording traces of 
Tac2-GFP neurons from OVX and OVX+E mice before, during and after 100 nM CRH 
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treatment. As reported (242), basal firing rate of Tac2-GFP neurons was higher in cells 
from OVX mice than those from OVX+E mice (Figure 3-6C, OVX 0.80±0.19 Hz, n=15 vs 
OVX+E 0.14±0.05 Hz, n=12, U= 19.5, P<0.001 two-tailed, Mann-Whitney U test). In 
OVX+E mice, CRH did not affect Tac2-GFP neuron firing rate (Figure 3-6D, Table 3-4 
for ANOVA parameters, control 0.10±0.05 Hz, CRH 0.10±0.04 Hz, wash 0.15±0.06 Hz, 
n=7, P>0.9, two-way repeated-measures ANOVA/Tukey, all comparisons). In OVX 
mice, the firing rate in 3 of 9 Tac2-GFP neurons increased by ≥30% during CRH 
treatment, but these cells exhibited further increases in firing rate during the wash 
period and it is this wash-associated increase that accounts for an apparent statistical 
significance  (Figure 3-6D, Table 3-4, control 0.77±0.25 Hz, CRH 0.85±0.24 Hz, wash 
1.35±0.28 Hz, n=9, P>0.8 control vs CRH, P=0.001 CRH vs wash, P=0.0003 control vs 
wash, two-way ANOVA/Tukey). Kisspeptin neurons of both the arcuate and 
anteroventral periventricular nuclei have been reported to increase firing rate over time 
without treatment (250,251). To distinguish a technical from a biological phenomenon, 
we performed the same recording paradigm with ACSF vehicle. A similar pattern of a 
mild increase during the time corresponding to treatment followed by a continued 
increase during the time corresponding to wash was observed (Figure 3-6D, Table 3-4, 
OVX+E n=5, con 0.22±0.09 Hz, vehicle 0.27±0.14 Hz, wash 0.69±0.43 Hz, P>0.99 all 
comparisons; OVX n=6, con 0.84±0.28 Hz, vehicle 0.87±0.31 Hz, wash 2.05±0.82 Hz, 
P>0.99 control vs “treatment”, P=0.0132 control vs “wash”, p=0.0159 “treatment” vs 
“wash”, two-way ANOVA/Tukey). These observations suggest the increase in firing rate 
observed in a minority of Tac2-GFP neurons in the OVX group is a technical 
phenomenon. 
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CRH does not acutely alter firing rate of Tac2-GFP-identified cells prepared in the 
low E negative feedback model 
Another possible caveat of the above study is that the suppressive effect of the daily 
surge OVX+E treatment suppressed firing activity of Tac2-GFP neurons to an extent 
that further acute inhibition by CRH cannot be observed. To address this, we used a low 
E model that mimics the diestrous state (117). The firing frequency of Tac2-GFP 
neurons from mice prepared in the low E model was higher those prepared in the daily 
surge model (Figure 3-7C). Nonetheless, CRH still had no effect on the firing activity of 
Tac2-GFP neurons in either OVX or OVX+E mice (Figure 3-7, Table 3-4, OVX n=8, con 
1.69±0.62 Hz, CRH 2.19±0.79, wash 2.19±0.75, P=0.12 control vs CRH, two-way 
ANOVA/Tukey; OVX+E n=8, con 0.80±0.20 Hz, CRH 0.93±0.28 Hz, wash 1.47±0.45 
Hz, P=0.87 control vs CRH, two-way ANOVA/Tukey). These results suggest that under 
the conditions examined, CRH does not acutely alter Tac2-GFP neuronal activity in 
cells from female mice. 
 
Activating CRHR-1 increases GABAergic transmission to GnRH neurons from 
OVX+E mice prepared in the daily surge model 
To test indirect actions of activating CRH receptors on GnRH neurons via GABAergic 
pathways, we examined the effect of stressin I or urocortin 3 on GABAergic PSCs in 
GnRH neurons in brain slices from OVX vs OVX+E mice. Figures 3-8A and 3-8C show 
representative traces from whole-cell voltage clamp recordings of GABAergic PSCs in 
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GnRH neurons from OVX and OVX+E mice before, during and after treatments. Neither 
stressin I (Figure 3-8A, B; n=7; control 0.51±0.14 Hz; stressin I 0.58±0.19 Hz; wash 
0.57±0.16 Hz; P>0.6, Table 3-5, two-way repeated-measures ANOVA/Tukey) nor 
urocortin 3 (Figure 3-8C, D; n=7; control 0.52±0.13 Hz; urocortin 3 0.55±0.14 Hz; wash 
0.46±0.12 Hz; P>0.7, Table 3-5, two-way repeated-measures ANOVA/Tukey) affected 
GABAergic PSC frequency in GnRH neurons from OVX mice. In contrast, in GnRH 
neurons from OVX+E mice, the CRHR-1 agonist stressin I increased GABAergic PSC 
frequency in 8 of 9 cells compared to the control period (Figure 3-8A, B; n=9; control 
0.43±0.14 Hz; stressin I 0.71±0.23 Hz; wash 0.59±0.19 Hz; P<0.001, Table 3-5, two-
way repeated-measures ANOVA/Tukey). The CRHR-2 agonist urocortin 3 did not affect 
GABAergic PSC frequency in GnRH neurons from OVX+E mice (Figure 3-8C, D; n=8; 
control 0.61±0.11 Hz; urocortin 3 0.53±0.11 Hz; wash 0.48±0.08 Hz; P>0.2, Table 5, 
two-way repeated-measures ANOVA/Tukey). The other PSC properties that were 
quantified were not altered by either stressin I or urocortin 3 during the treatment period 
(Figure 3-9A-C). There were no differences in passive properties among groups (Table 
3-6). These results suggest that activation of CRHR-1 increases the frequency of 
GABAergic transmission to GnRH neurons, which because of the excitatory effect of 
GABA on these cells (153,154) could explain the reported increase in GnRH neuron 
firing activity during CRHR-1 agonist treatment (238).  
 
Discussion 
Reproduction is regulated by the central nervous system via GnRH neurons, which form 
the final common pathway that integrates inputs and releases GnRH to regulate the 
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anterior pituitary’s production of gonadotropins. Stress can alter reproduction at many 
levels, including disruption of estradiol positive feedback action. In brain slices from 
unstressed mice prepared in a model of estradiol positive feedback, treatment with 
CRH, a mediator that is released centrally during the stress response, exerts both 
stimulatory and inhibitory effects on GnRH neuron activity (238). Here we provide 
evidence that stimulatory effects of CRH receptor activation are, at least in part, 
mediated by increased GABAergic transmission frequency to GnRH neurons. The 
mechanisms for inhibition of GnRH neurons by CRH remain elusive. 
 
These observations support and extend prior evidence that GABA is involved in 
mediating both CRH- and stress-induced alterations of reproductive hormones. 
Injections of CRH into the bed nucleus of the stria terminalis or locus coeruleus 
increased Fos expression in GAD67-identified GABAergic neurons in the medial 
preoptic area, suggesting increased cellular activity of these cells (165,252). 
Administration of a GABAA receptor antagonist into the preoptic region blocks stress-
induced suppression of LH pulses (162). In these studies, it is not possible to know the 
specific cell types affected by treatments. In the present study, bath-application of a 
CRHR-1 agonist to brain slices increased frequency of GABAergic transmission to 
GnRH neurons. GABA can induce action potential firing in GnRH neurons because 
these cells maintain high intracellular chloride levels (153,154). The observed increase 
in GABA transmission could thus explain the stimulatory effect of activation of CRHR-1 
on GnRH neuron firing activity in brain slices (238).  
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The stimulatory effect of activating CRHR-1 on GABAergic transmission to GnRH 
neurons is dependent upon circulating estradiol. Estradiol also influences the 
reproductive response to hormones of the HPA axis in vivo. In OVX ewes, cortisol 
treatment suppresses LH pulse amplitude without affecting LH pulse frequency, 
suggesting no effect on GnRH release frequency (74). In contrast, in ewes given 
follicular-phase estradiol levels, cortisol inhibits both LH pulse amplitude and frequency, 
and reduces GnRH pulse frequency (61,75,76). Inhibitory effects of CRH on LH pulse 
frequency and amplitude are also stronger in OVX+E than OVX rats (81). Consistent 
with these in vivo measures, CRH altered GnRH neuron firing rate in cells from OVX+E 
but not OVX mice (238). These observations likely involve an estradiol-sensitive 
network upstream of GnRH neurons as estrogen receptor alpha is typically not detected 
in these cells (253). Supporting this postulate, changing circulating levels of estradiol 
alters other neuromodulatory effects on GnRH neurons. For example, the enhanced 
excitation of GnRH neurons elicited by kisspeptin in OVX+E vs OVX mice is in part 
attributable to kisspeptin increasing GABAergic transmission to GnRH neurons in the 
former but not the latter (244,254). Estradiol also enables time-of-day shifts in 
GABAergic transmission to GnRH neurons (157) and induces synaptic plasticity in 
several brain regions, including the hypothalamus (255-257). Of interest, CRHR-1 and 
estrogen receptor alpha are coexpressed in non-kisspeptin neurons in the anteroventral 
periventricular nucleus; cells in this area are activated following stress based on 
phosphorylated CREB expression (151). It is important to point out that OVX models 
largely alter the circulating ovarian hormone levels. Steroids are also synthesized in the 
brain, and it is possible that local central steroids affect responses to the treatments 
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used (258,259). Together, these observations suggest an integral link between estradiol 
and GABAergic inputs to GnRH neurons that might be attributable to estradiol-induced 
changes in synaptic connectivity between these cell types.  
 
The established role of CRHR-2 in inhibiting reproduction appears to utilize alternative 
mechanisms. Blocking CRHR-2 prevents restraint-induced suppression of LH pulses 
and central injection of a CRHR-2 agonist (urocortin 2) reduced LH pulse frequency in 
female rats (86). Similarly, activating CRHR-2 with urocortin 3 inhibits GnRH neuron 
firing activity in brain slices (238). The frequency of GABAergic postsynaptic currents is 
modified by a number of factors that influence GnRH output, including development, 
steroids and nutritional status, indicating these inputs are a major node for integration 
(156-158,260). Reduction in frequency of GABA transmission to GnRH neurons does 
not, however, appear to convey the inhibitory actions of CRH receptor activation within 
the brain slice preparation. It is possible that GABA afferents of GnRH neurons that are 
affected by CRH receptor activation are not included within the slice. CRH-induced 
changes in GABAergic transmission to GnRH-neuron afferents cannot be excluded, nor 
can changes in fast glutamatergic transmission. Of note, the latter is very low frequency 
in GnRH neurons (209,261), thus reducing excitation through this route is not a likely 
explanation for inhibitory actions of CRH. 
 
Like GABAergic neurons, KNDy neurons of the hypothalamic arcuate nucleus are a 
major afferent regulator of episodic GnRH/LH release. These cells produce kisspeptin 
and neurokinin B, both of which increase GnRH neuron output (141,142,254,262). They 
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also produce dynorphin; activation of dynorphin receptors in vivo reduces LH pulse 
frequency (263,264). These cells could thus potentially mediate both activating and 
inhibitory actions of stress on the reproductive neuroendocrine system. CRH, however, 
did not acutely alter firing rate of KNDy neurons under either of the circulating estradiol 
feedback experimental conditions tested. This initially appears contrary to several 
studies showing that stress might act on KNDy neurons. For example, restraint, 
metabolic and immunological stress all decreased Kiss1 mRNA expression in the 
arcuate nucleus, as did intracerebroventricular injection of CRH (65). KNDy neurons 
have been reported to express CRH receptors in rats (150) and stress suppressed 
KNDy neural activation as determined by Fos expression in both male and female mice 
(148,265). The effects on Fos expression were observed three hours after stress 
exposure thus acute vs more chronic changes in activity cannot be distinguished. Of 
note, Fos expression can be induced by stimuli other than neuronal firing, such as 
growth factors (266). One possible explanation of these observations is that the effects 
of stress and CRH on KNDy neurons are more targeted towards longer-term actions, 
such as altering the profile of peptides expressed in these cells. This could affect their 
secretory output independent of a change in firing rate; this postulate is supported by 
reports of stress altering kisspeptin expression in the arcuate nucleus (65).  
 
In addition to indirect actions of CRH and CRHR agonists, we examined possible 
intrinsic targets. Voltage-gated potassium channels play a key role in regulating 
neuronal activity by influencing resting membrane potential and latency to spike 
initiation (267,268). In GnRH neurons, these currents help mediate estradiol negative 
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and positive feedback, with shifts in both density and voltage dependence (197,246). In 
the present study, the same treatment paradigms that acutely altered GnRH neuron 
activity (238) failed to alter the current density of either IA or IK in GnRH neurons. It is 
still possible that activation of CRH receptors might affect other potassium current 
properties such as the voltage-dependence of activation or inactivation (200). The 
voltage protocols used in the present study were intentionally abbreviated to increase 
the rigor of our measurements as potassium current amplitude is very sensitive to time 
and recording quality.  
 
As a broader test of intrinsic changes in GnRH neurons in response to CRH, we 
examined excitability. Neither CRH nor a CRHR-1 agonist altered excitability of GnRH 
neurons in slices from OVX+E mice. Unlike CRHR-1, activation of CRHR-2 increased 
excitability in about one-third of GnRH neurons, but the overall excitability of the group 
was not different. This may represent a subpopulation that is responsive. Alternatively, 
activation of CRHR-2 on neuromodulatory afferents that either activate or suppress 
GnRH neurons may explain some of this variability. Because GnRH neurons are widely 
distributed, the possible afferents remaining with each slice are different. Neuronal 
computation of direct and indirect effects may thus result in increased excitability in 
some cases.  
 
The lack of observation of consistent direct effects of CRH receptor activation for either 
intrinsic mechanism studied raises the question of receptor expression by GnRH 
neurons. We took advantage of CRHR-1 reporter mice to identify receptor-expressing 
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cells. No colocalization was observed between CRHR-1 and GnRH in either male and 
female mice, which confirms and extends a previous report in male mice (131). CRH 
receptor expression has been reported in about one-third of GnRH neurons (269), but 
identification of G-protein-coupled receptors via immunochemistry is complicated by 
their low expression levels. The antibody used in that study did not distinguish CRHR 
subtype (269). While it remains possible that the receptor detected was CRHR-2, no 
colocalization between GnRH and CRHR-2 detected by CRHR-2-driven cre 
recombinase and floxed reporter was observed in male mice (131). Another possible 
explanation for the negative physiologic results is that more robust activation of either 
CRHR subtype may have revealed a different outcome. While we cannot exclude this 
possibility, the agonist doses used in the present studies are both selective and 
effective at inducing changes in GnRH neuron firing rate in the brain slice preparation. 
 
The present work examined four possible mechanisms to explain the effects of CRH on 
GnRH neuron activity. Three of these mechanisms were not supported as being 
involved in this acute response, but by indicating their likely lack of involvement, our 
studies sculpt future studies investigating other mechanisms. It is important to point out 
that these negative results were obtained in cells from mice with high physiologic levels 
of circulating estradiol, because these are the same experimental conditions and time 
frames under which GnRH neurons responded to CRH (238). The present work did 
identify an estradiol-dependent increase in GABA transmission as being, at least in part, 
responsible for the estradiol-dependent increase in GnRH neuron firing rate induced by 
CRHR-1 activation. The interactions among the HPG and HPA axes are complicated 
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and the quest for inhibitory mediators, as well as other stimulatory mediators, continues. 
With regard to the former, reports that stress may activate neurons expressing 
gonadotropin-inhibitory hormone, a neuromodulator that can inhibit GnRH neurons, 
bears further examination (148,171,173,265). 
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Table 3-1. Mean±SEM and statistical parameters for current density and whole-cell 
passive properties of GnRH neurons (Figure 1) 
 
  Control Stressin I t, df, P 
IA density (pA/pF) 452.4±101.0 407.7±92.0  1.7, 6, 0.1 
IK density (pA/pF) 157.0±40.3 152.7±37.8  0.8, 6, 0.4 
Rin (MΩ) 802±122 698±83 2.0, 6, 0.1 
Capacitance (pF) 12.7±1.5 12.6±1.5 1.1, 6, 0.3 
Rs (MΩ) 14.9±0.7 16.3±0.6 2.2, 6, 0.1 
Ihold (pA) -13.3±7.1 -33.9±10.7 2.2, 6, 0.1 
  Control Urocortin 3 t, df, P 
IA density (pA/pF) 309.9±51.5 286.7±43.1 1.8, 6, 0.1 
IK density (pA/pF) 96.1±15.9  94.5±14.9  0.5, 6, 0.6 
Rin (MΩ) 867±103 799±120 1.4, 6, 0.2 
Capacitance (pF) 15.2±1.2 14.8±1.0 1.0, 6, 0.3 
Rs (MΩ) 14.6±0.7 14.6±0.8 0.1, 6, 0.9 
Ihold (pA) -18.0±3.9 -21.4±4.1 1.7, 6, 0.1 
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Table 3-2. Mean±SEM and one- or two-way-repeated-measures ANOVA statistical 
parameters for excitability of GnRH neurons (Figures 2, 3, 4) 
 
#spikes per current injection Treatment Current steps Interaction 
CRH (Fig 2B) F(1,6)=0.21 F(19,114)=74.26* F(19,114)=0.37 
Stressin I (Fig 3B) F(1,6)=1.74 F(19,114)=38.52* F(19,114)=1.77 
Urocortin 3 (Fig 4B) F(1,7)=1.09 F(19,133)=26.24* F(19,133)=1.06 
*P<0.0001 
CRH (n=7) Control CRH  Wash F, P (One-way RM ANOVA) 
pA to first spike 15.1±1.4 16.6±1.5 17.1±2.1 0.6, 0.51 
ap width (ms) 0.76±0.04 0.76±0.04 0.74±0.04 1.5, 0.26 
amplitude (mV) 95.7±1.5 93.8±1.6 94.2±2.4 1.5, 0.26 
threshold (mV) -47.9±1.2 -47.7±1.2 -47.8±1.4 0.2, 0.73 
rate rise (mV/ms) 582.6±23.3 543.8±28.9 541.1±40.4 2.4, 0.17 
AHP amplitude (mV) -23.4±0.7 -23.7±0.9 -23.85±0.6 0.2, 0.70 
AHP time (ms) 3.9±0.2 3.6±0.2 3.5±0.3 3.6, 0.06 
AHP min (mV) -71.4±1.4 -71.4±1.6 -71.6±1.1 0.1, 0.86 
 
Stressin I (n=7)  Control Stressin I  Wash F, P (One-way RM ANOVA) 
pA to first spike 17.1±2.0 18.0±2.4 21.1±2.1 2.9, 0.13 
ap width (ms) 0.76±0.05 0.78±0.04 0.76±0.04 0.7, 0.46 
amplitude (mV) 97.9±3.0 96.2±2.3 95.9±1.9 0.5, 0.53 
threshold (mV) -44.2±1.3 -43.8±1.3 -43.7±1.5 0.5, 0.60 
rate rise (mV/ms) 554.0±18.7 557.5±15.1 536.9±16.9 2.2, 0.16 
AHP amplitude (mV) -25.4±0.4 -25.6±0.8 -24.6±0.9 0.9, 0.42 
AHP time (ms) 4.0±0.3 4.1±0.3 3.7±0.4 2.3, 0.15 
AHP min (mV) -69.6±1.4 -69.3±1.5 -68.2±1.4 2.3, 0.16 
 
Urocortin 3 (n=8)  Control Urocortin 3  Wash 
F, P (One-way RM 
ANOVA) 
pA to first spike 21.3±2.8 19.3±3.5 14.3±3.9 2.4, 0.15 
ap width (ms) 0.86±0.05 0.85±0.05 0.84±0.05 0.7, 0.52 
amplitude (mV) 89.8±2.1 89.3±1.7 89.5±2.6 0.1, 0.83 
threshold (mV) -46.1±1.2 -47.7±1.6 -49.0±2.1 3.2, 0.10 
rate rise (mV/ms) 463.2±38.6 449.5±36.5 461.0±44.8 0.3, 0.72 
AHP amplitude (mV) -24.9±1.1 -24.8±1.0 -24.5±1.2 0.2, 0.70 
AHP time (ms) 4.0±0.4 3.8±0.4 3.9±0.3 0.9, 0.40 
AHP min (mV) -70.9±1.7 -72.4±1.7 -73.5±1.5 3.0, 0.11 
 
 
 
 
73 
Table 3-3. Mean±SEM of GnRH neuron whole-cell passive properties and statistical 
parameters for excitability recordings (Figures 2,3,4) 
 
CRH (n=7)  Control CRH  Wash Statistical parameters 
Rin (MΩ) 841±60 715±76 689±63 P=0.11 (Friedman test) 
Capacitance 
(pF) 15.2±1.2 15.4±0.9 15.4±1.1 
F=0.3, P=0.65 (One-way RM 
ANOVA) 
Rs (MΩ) 14.0±0.5 13.9±1.0 14.2±0.8 F=0.3, P=0.63 (One-way RM ANOVA) 
Ihold (pA) -11.1±5.8 -13.7±5.0 -15.3±5.5 
F=3.9, P=0.06 (One-way RM 
ANOVA) 
Stressin I (n=7) Control Stressin I  Wash  
Rin (MΩ) 973±75 991±76 875±91 F=1.9, P=0.19 (One-way RM ANOVA) 
Capacitance 
(pF) 13.1±1.3 12.82±1.3 12.9±1.4 
F=0.2, P=0.71 (One-way RM 
ANOVA) 
Rs (MΩ) 14.9±0.9 15.2±0.4 17.6±0.6 F=0.8, P=0.42 (One-way RM ANOVA) 
Ihold (pA) -14.3±3.9 -16.9±3.7 -21.7±4.0 
F=4.9, P=0.06 (One-way RM 
ANOVA) 
Urocortin 3 
(n=8) Control Urocortin 3 Wash 
 
Rin (MΩ) 814±93 816±100 915±109 P=0.79 (Friedman test) 
Capacitance 
(pF) 12.9±1.6 12.9±1.9 12.8±1.9 
F=0.05, P=0.88 (One-way 
RM ANOVA) 
Rs (MΩ) 14.5±0.9 15.0±1.1 15.4±1.1 F=2.3, P=0.17 (One-way RM ANOVA) 
Ihold (pA) -18.6±5.6 -17.5±7.0 -17.3±5.7 
F=0.2, P=0.82 (One-way RM 
ANOVA) 
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Table 3-4. Two-way, repeated-measures ANOVA statistical parameters for extracellular 
Tac2-GFP neuron recordings in the daily surge model (Figure 6) and low E model 
(Figure 7). 
 
CRH (daily surge) Steroid milieu Treatment Interaction 
Firing frequency F(1,14) = 10.32* F(2,28) = 6.28* F(2,28) = 4.40* 
CRH (low E) Steroid milieu Treatment Interaction 
Firing frequency F(1,14) = 1.55 F(2,28) = 5.60* F(2,28) = 1.22 
Vehicle Steroid milieu Treatment Interaction 
Firing frequency F(1,9) = 2.47 F(2,18) = 5.65* F(2,18) = 1.20 
*P<0.05    
 
 
 
Table 3-5. Statistical parameters for GABA PSC properties (Figures 8,9). All main 
effects of treatment other than PSC frequency during stressin I treatment were 
attributable to changes during only the wash period. 
 
Stressin I Steroid milieu Treatment Interaction 
PSC frequency (Fig 
7B) F(1,14) = 0.01 F(2,28) = 6.13** F(2,28) = 2.09 
amplitude (Fig 8A) F(1,14) = 0.57 F(2,28) = 0.18 F(2,28) = 1.48 
decay time (Fig 8B) F(1,14) = 1.26 F(2,28) = 6.92** F(2,28) = 2.16 
fwhm (Fig 8C) F(1,14) = 0.28 F(2,28) = 9.47** F(2,28) = 0.49 
Urocortin 3 Steroid milieu Treatment Interaction 
PSC frequency (Fig 
7D) F(1,13) = 0.04 F(2,26) = 4.72* F(2,26) = 1.62 
amplitude (Fig 8A) F(1,13) = 2.09 F(2,26) = 0.33 F(2,26) = 1.80 
decay time (Fig 8B) F(1,13) = 0.58 F(2,26) = 4.29 F(2,26) = 0.54 
fwhm (Fig 8C) F(1,13) = 0.47 F(2,26) = 10.76** F(2,26) = 0.27 
*P<0.05, **P<0.01    
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Table 3-6. Mean±SEM of GnRH neuron whole-cell passive properties and statistical 
parameters for GABA PSC recordings (Figures 8,9) 
 
Stressin I (OVX+E) Control Treatment Wash 
Rin (MΩ) 918±149 855±119 905±124 
Capacitance (pF) 15.8±1.1 15.8±1.4 15.9±1.4 
Rs (MΩ) 14.5±1.0 16.3±1.4 16.1±1.4 
Ihold (pA) -26.5±7.1 -29.1±8.3 -31.7±8.9 
Urocortin 3 (OVX+E) Control Treatment Wash 
Rin (MΩ) 840±140 796±150 653±104 
Capacitance (pF) 16.2±1.4 15.8±0.9 15.6±1.1 
Rs (MΩ) 13.6±1.3 14.4±1.3 15.2±1.0 
Ihold (pA) -29.8±7.9 -49.9±21.6 -37.9±11.1 
Stressin I (OVX) Control Treatment Wash 
Rin (MΩ) 1027±88 956±77 841±95 
Capacitance (pF) 11.8±1.4 11.2±1.5 11.2±1.3 
Rs (MΩ) 17.8±0.6 18.0±0.8 17.8±0.5 
Ihold (pA) -24.4±3.7 -26.2±4.2 -25.3±4.6 
Urocortin 3 (OVX) Control Treatment Wash 
Rin (MΩ) 866±114 888±107 788±99 
Capacitance (pF) 15.4±2.4 14.4±2.3 14.5±2.2 
Rs (MΩ) 15.4±1.2 14.8±1.6 15.9±1.2 
Ihold (pA) -26.2±6.5 -40.6±10.8 -34.8±8.8 
 
Stressin I Steroid milieu Treatment Interaction 
Rin (MΩ) F(1,14) = 0.09 F(2,28) = 1.64 F(2,28) = 1.51 
Capacitance (pF) F(1,14) = 5.34 F(2,28) = 0.42 F(2,28) = 0.58 
Rs (MΩ) F(1,14) = 2.30 F(2,28) = 2.20 F(2,28) = 1.57 
Ihold (pA) F(1,14) = 0.15 F(2,28) = 1.21 F(2,28) = 0.69 
Urocortin 3 Steroid milieu Treatment Interaction 
Rin (MΩ) F(1,13) = 0.27 F(2,26) = 3.58 F(2,26) = 0.50 
Capacitance (pF) F(1,13) = 0.20 F(2,26) = 3.06 F(2,26) = 0.48 
Rs (MΩ) F(1,13) = 0.32 F(2,26) = 1.67 F(2,26) = 0.82 
Ihold (pA) F(1,13) = 0.12 F(2,26) = 2.68 F(2,26) = 0.11 
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Figures and Legends 
 
Figure 3-1.  Activation of CRH receptors does not affect amplitude of voltage-gated 
potassium currents in GnRH neurons from OVX+E mice during positive feedback. (A-B) 
Representative traces of IA and IK during control (black) and treatment (stressin I in 
cyan, urocortin 3 in magenta) in GnRH neurons. (C-D) IA or IK current density of 
individual GnRH neurons during control, and stressin I or urocortin 3 treatment. 
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Figure 3-2.  CRH does not affect GnRH neuron excitability. (A) Representative traces 
under control and CRH treatment conditions in OVX+E mice during positive feedback. 
(B) Mean±SEM number of action potentials elicited by each current injection step. (C-J) 
individual values during control, CRH treatment, and wash out periods. (C) Current 
required to generate first action potential. (D) Action potential width. (E) Action potential 
amplitude. (F) Action potential threshold. (G) Action potential rate of rise. (H) AHP 
amplitude. (I) AHP time. (J) AHP minimum. 
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Figure 3-3.  Activation of CRHR-1 with stressin I (St) does not affect GnRH neuron 
excitability in OVX+E mice during positive feedback. (A) Representative traces under 
control and stressin 1 treatment conditions. (B) Mean±SEM spikes elicited by each 
current injection step. (C-J) individual values during control, stressin I (St) treatment, 
and wash out periods. (C) Current required to generate first action potential. (D) Action 
potential width. (E) Action potential amplitude. (F) Action potential threshold. (G) Action 
potential rate of rise. (H) AHP amplitude. (I) AHP time. (J) AHP minimum. 
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Figure 3-4.  Activation of CRHR-2 with urocortin 3 (U3) does not affect GnRH neuron 
excitability in OVX+E mice during positive feedback. (A) Representative traces under 
control and urocortin 3 treatment conditions. (B) Mean±SEM spikes elicited by each 
current injection step. (C-J) individual values during control, urocortin 3 treatment, and 
wash out periods. (C) Current required to generate first action potential (rheobase). 
Green lines indicate cells exhibited decrease in rheobase during the treatment. (D) 
Action potential width. (E) Action potential amplitude. (F) Action potential threshold. (G) 
Action potential rate of rise. (H) AHP amplitude. (I) AHP time. (J) AHP minimum. 
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Figure 3-5. Dual-labeling of GnRH immunoreactivity and CRHR-1-GFP 
immunoreactivity. Representative images of GnRH and CRHR-1-GFP labeling in the 
preoptic area of female diestrus (A-C), male (E-G), or OVX+E female (I-K) mouse. The 
inset boxes (C, G and K) indicate areas further magnified in (D, H and L). No co-labeling 
was found although GnRH and CRHR-1-GFP neurons were often in proximity.
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Figure 3-6. CRH does not alter firing rate of Tac2-GFP neurons from mice prepared in 
the daily surge positive feedback model. (A-B) Representative extracellular recordings 
of Tac2-GFP neurons OVX (A) and OVX+E (B) mice during each experimental period. 
(C) Firing rate of individual Tac2-GFP neurons from daily surge OVX and OVX+E mice 
during the control period. *P<0.001 two-tailed, Mann-Whitney U test. (D) Firing 
frequency of individual Tac2-GFP neurons during control (C), CRH (left) or vehicle (veh) 
(right) treatment, and wash out (W) periods. Green lines indicate cells with ≥40% 
increase in firing frequency during treatment, attributable to recording instability 
increasing firing rate during the wash period.
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Figure 3-7. CRH does not alter firing rate of Tac2-GFP neurons from mice prepared in 
the low E negative feedback model of diestrus. (A-B) Representative extracellular 
recordings of Tac2-GFP neurons OVX (A) and OVX+ low E (B) mice during each 
experimental period. (C) Firing rate of individual Tac2-GFP neurons from the four 
groups examined (data from Figure 6C are repeated for ease of comparison); Kruskal-
Wallis (KW=16.8, p~0.0008)/Dunn’s post hoc * p range 0.003-0.03. (D) Firing frequency 
of individual Tac2-GFP neurons during control (C), CRH (left) or vehicle (veh) (right) 
treatment, and wash out (W) periods. Green/red lines indicate cells with ≥40% 
increase/decrease in firing frequency during treatment.  
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Figure 3-8. Activation of CRHR-1 with stressin I (St) but not CRHR-2 with urocortin 3 
(U3) increases GABAergic transmission frequency to GnRH neurons in OVX+E mice. 
(A) Representative whole-cell voltage-clamp recordings of GnRH neurons treated with 
stressin I (St), top OVX, bottom OVX+E. (B) PSC frequency of individual GnRH neurons 
during control (C), stressin I, and wash out (W) periods. (C) Representative whole-cell 
voltage-clamp recordings of GnRH neurons treated with urocortin 3 (U3), top OVX, 
bottom OVX+E. (D) PSC frequency of individual GnRH neurons during control (C), 
urocortin 3 and wash out (W) periods. Green and red lines indicate cells with ≥30% 
increase or decrease in PSC frequency during treatment, respectively. *P<0.05 PSC 
frequency compared with control period, two-way repeated-measures ANOVA/Tukey. 
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Figure 3-9. Activation of either CRHR-1 or CRHR-2 has no effect on PSC amplitude or 
kinetics in GnRH neurons regardless of estradiol status. (A-C) PSC properties of 
individual GnRH neurons during control (C), stressin I (St) or urocortin 3 (U3) treatment 
and wash out (W) periods. Green and red lines indicate cells with ≥30% increase or 
decrease in each parameter during treatment, respectively.
 
 
 
85 
Chapter 4: Conclusion 
 
This dissertation examined central mechanisms of the effect of stress by examining the 
action of CRH on reproduction. We observed that CRH indeed exerts effects on GnRH 
neuron activity as measured by the action potential firing rate of these cells in acutely-
prepared brain slices. We further studied both indirect and direct neurobiological 
mechanisms of how CRH acts on GnRH neurons. The summary of the findings in this 
study is illustrated in the Figure 4-1. 
 
Actions of CRH on GnRH neuron firing activity 
CRH was postulated to be involved in stress-induced alteration of the HPG axis. In 
Chapter 2, effects of CRH on GnRH neuron firing activity were tested. We found that 
CRH could elicit both inhibitory and stimulatory effects on GnRH neurons depending on 
concentration of CRH and CRHR subtype activated. The direction of response to CRH 
was determined by the concentration of CRH, with high and low concentrations of CRH 
decreasing and increasing firing frequency in GnRH neurons, respectively. We 
postulated that the different responses we observed resulted from different subtype of 
CRHR activated. Using CRHR specific agonists, we found that the suppressive effect of 
CRH on GnRH neuron firing activity is mediated through CRHR-2. Other studies have 
also noted the involvement of CRHR-2 signaling on stress-induced suppression of the 
HPG axis. ICV injection of urocortin II, for which CRHR-2 has high affinity and CRHR-1 
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low affinity, suppresses LH pulse frequency and amplitude in female rats (86). 
Furthermore, the inhibitory effects of metabolic, psychological, and immunological 
stressors on LH secretion are abolished by icv injection of CRHR-2 antagonists (85). 
Taken together these data suggest that the inhibitory effect of stress is mediated by 
CRHR-2 signaling to alter GnRH neuron output, which then could affect the LH pulse 
secretion. 
 
Unexpectedly, CRH also exhibited stimulatory effects on GnRH neurons via CRHR-1. 
This helps explain the previous studies that discovered acute stimulatory effects of 
stress on the reproductive system in some conditions (92,114). Proestrous rats exposed 
to acute restraint stress showed increased in LH and FSH secretion and blocking 
CRHR-1 signaling prevented the stimulatory effects of acute restraint stress on 
gonadotropin secretion, whereas a CRHR-2 antagonist did not alter the stimulatory 
effect of restraint stress (90,91). Further experiments in vivo are needed to test whether 
or not activation of CRHR-1 signaling would provide a stimulatory effect on either 
GnRH/LH release or the reproductive outcome. For example, one should test if 
activation of CRHR-1 signaling using a specific agonist would lead to an increase in LH 
pulse frequency or amplitude. It is important to note that the stimulatory effect of CRH 
on GnRH neurons does not necessary mean that stress enhances reproductive 
function. Continuous GnRH treatment suppresses LH and FSH secretion, whereas 
pulsatile treatment of GnRH maintains LH and FSH (18). Therefore, if GnRH release is 
constantly high due to activation by CRH, it could paradoxically lead to decrease in 
LH/FSH secretion and suppress the reproductive system.  
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The effects of CRH on GnRH neurons observed in this study are estradiol-dependent. 
In OVX mice, no effects of CRH on GnRH neuron activity were observed. This suggests 
that estradiol plays a role in enabling the response to CRH in GnRH neurons. These 
finding support and extend previous work showing that estradiol potentiates the effects 
of stress on reproduction in the whole animal level. The inhibitory effects of stress or 
CRH on LH pulse frequency are prominent in animals with high estradiol levels 
(77,110,111). The mechanism of how estradiol influences the stress response is not 
known yet. There are several possibilities that could underlie the effect of estradiol. For 
example, the expression of CRHR may be regulated by estradiol. In this regard, 
proestrous rats, which have highest estradiol during the estrous cycle, showed higher 
CRHR expression compared to diestrous rats (102). Moreover, estradiol could 
potentially regulate CRHR expression at transcription level because CRHR-2 promoter 
contains an estrogen receptor response element (104). Another possibility is that 
estradiol may enhance the responsiveness in GnRH neurons by modifying the synaptic 
interactions from upstream neurons of GnRH neurons as estradiol has been shown to 
affect synaptic interactions in the hypothalamus (205). These hypotheses remain to be 
tested to obtain more information of how the HPG axis regulates the HPA axis. 
 
In addition to firing frequency, CRH also altered short-term burst firing pattern in GnRH 
neurons from OVX+E mice. Burst firing has historically been associated with hormonal 
secretion in neuroendocrine cells (194,222,223). Activation of CRHR-2 or high doses of 
CRH (100nM) led to decreases in the burst frequency in GnRH neurons from OVX+E 
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mice. In contrast, activation of CRHR-1 increased burst firing in GnRH neurons from 
OVX+E mice. In OVX mice, CRH did not affect mean firing frequency of GnRH neurons 
but it is possible that CRH could alter the burst firing pattern. However, neither high nor 
low concentrations of CRH appeared to change any of burst firing parameters in GnRH 
neurons from OVX mice. Taken together with the observation in GnRH neuron firing 
frequency, CRH has both excitatory and inhibitory on GnRH neurons both on mean 
firing activity and the burst firing pattern. This could eventually lead to changes in GnRH 
release at the terminal. The finding of bidirectional effects of CRH on GnRH neurons in 
this dissertation provides an explanation for the bidirectional effects of stress on 
reproductive system from previous studies and open possibilities for future direction in 
the field. For example, which endogenous ligands (CRH or urocortin family) are 
responsible for the inhibitory or stimulatory effects on HPG axis, does the stimulatory 
effect of CRH on GnRH neurons lead to increase in GnRH release from the terminal, 
and do inhibitory and stimulatory effects of stress happen at the same time points or 
different time points from a stress onset.  
 
The mechanisms of how CRH acts on GnRH neurons 
The work in the Chapter 2 shows that GnRH neuron activity is regulated by CRH. 
Chapter 3 examined mechanisms. There are two possible pathways that could mediate 
the effect of CRH on GnRH neurons, direct and indirect. First, we tested if CRH acts 
directly on GnRH neurons. Previous studies have shown that neuromodulators, such as 
kisspeptin, regulate GnRH neurons via modulation of voltage-gated potassium currents 
(200). In this study, two types of voltage-gated potassium currents were recorded from 
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GnRH neurons with CRHR-1 or CRHR-2 agonist treatment. Neither CRHR-1 or CRHR-
2 agonist affected the current densities of either transient or sustained potassium 
currents in GnRH neurons. Although the amplitude of potassium currents was not 
affected by CRH treatment, it is possible that other properties such as a shift in voltage-
dependent in activation or inactivation of potassium currents might be affected. Another 
possibility is that CRH does not modulate voltage-gated potassium currents but rather 
acts through other ionic conductances in GnRH neurons. We broadly explored the 
possible direct action of CRH by determining if the excitability of GnRH neurons is 
affected by CRH. Again, there was no difference in action potential generated by GnRH 
neurons before and during CRH treatment. The expression of CRHR by GnRH neurons 
is still controversial with evidence of presence and absence of expression (127,131). 
CRHR is a GPCR, thus the detection of CRHR expression is difficult due to the typically 
low expression levels of GPCRs. Our immunofluorescent data showed no colocalization 
observed between CRHR-1 and GnRH neuron in either female (diestrous and OVX+E) 
or male mice. While it remains possible that the CRHR presence in the GnRH neurons 
was CRHR-2, no colocalization between GnRH and CRHR-2 detected by CRHR-2-
driven cre recombinase and floxed reporter was observed in male mice (131). 
 
To explore possible indirect actions of CRH, we first tested the effect of CRH on arcuate 
kisspeptin (aka KNDy) neurons in the hypothalamus. KNDy neurons provide an 
estradiol-dependent stimulatory signal to GnRH neurons. The firing activity of KNDy 
neurons was not affected by CRH treatment either in the OVX or OVX+E group. 
Although some of the cells showed tendency to have elevated firing frequency after 
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CRH treatment, the vehicle treatment showed the same increase in firing rate as those 
observed during CRH treatment. Previous studies also noticed the increased in firing 
activity over time in kisspeptin neurons both in arcuate nucleus and anteriorventral 
periventricular nuclei (270,271). This result suggests that CRH has no acute effect on 
KNDy activity. One caveat in this study is that the basal firing activity of KNDy neurons 
in OVX+E mice is low due to the negative feedback of estradiol. If CRH exhibits 
inhibitory effect on KNDy neurons, it would be hard to observe a decrease in firing 
activity. We therefore employed an OVX+low E model in which the basal firing rate in 
KNDy neurons is higher than that of OVX+E daily surge model. CRH again did not 
acutely affect firing rate of KNDy neurons from OVX+low E mice. Another possibility is 
that the effect of CRH on KNDy neurons is chronic rather than acute. At whole animal 
level, KNDy neurons showed a reduction in neuronal activation marker (Fos) at much 
later time point (3h) from stress induction (148) than the acute actions we examined. 
Another possibility is that stress/CRH affects the peptide production in the KNDy 
neurons and lead to an eventual change in neuromodulator release without affecting the 
firing activity of these cells. Therefore, the option that KNDy neurons might be involved 
in CRH-induced alteration of GnRH neuron activity cannot be ruled out.  
 
GABA is a crucial signal regulating GnRH neuron activity. In Chapter 3, results 
demonstrated that activation of CRHR-1 increased GABAergic PSC frequency to GnRH 
neurons from OVX+E mice. In contrast to majority of the brain, GABA is excitatory to 
GnRH neurons due to the high intracellular chloride levels in these cells (153,154). 
Thus, the stimulatory effect of CRHR-1 agonist on firing activity of GnRH neurons 
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shown in the Chapter 2 could stem at least in part from the increase in GABAergic 
transmission to GnRH neurons. Interestingly, CRHR-1 appears to be expressed in 
GABAergic neurons in preoptic area that are located near GnRH neurons (131). 
Further, GABAergic neurons in medial preoptic area showed increased in neuronal 
activation (indicated by Fos expression) after CRH injection into bed nucleus of stria 
terminalis or locus coeruleus (164,165). Although in our study activation of CRHR-2 did 
not affect GABAergic transmission to GnRH neurons, it is possible that it could alter 
GABAergic inputs to other afferents of GnRH neurons. GnRH neurons also receive 
glutamatergic input, although glutamatergic input frequency is much lower than that of 
GABAergic inputs (209,272). Nonetheless, there is a possibility that CRH could affect 
glutamatergic inputs to GnRH neurons and alter GnRH neuron activity, or use 
glutamatergic intermediates to activate other modulators of GnRH neurons. These 
findings together with our results suggest that GABAergic signaling could be the 
underlying pathway in stress/CRH-induced stimulation of reproduction.  
 
Role of CRH in stress-induced alteration of HPG axis in vivo 
The work in Chapter 2 and 3 explored the effect of CRH on GnRH neurons in various 
aspects in brain slices. An important future direction of this work is to study the role of 
CRH on HPG axis in vivo. One of the reproductive functions that has been shown to be 
interrupted by stress is the generation of LH surge (118,119). Continuous infusion of 
CRH or single injection of CRH before the onset of LH surge diminished LH surge 
amplitude in proestrous rats (123). Therefore, the stress-induced suppression of might 
be mediated by CRH. With the development of the chemogenetic manipulation 
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technique called designer receptors exclusively activated by designer drugs 
(DREADDs), the activity of targeted cells could be manipulated using either activating 
(HM3Dq) or inhibitory (HM4Di) designer receptors. To test if CRH is required for the 
suppression of LH surge, inhibitory DREADDs could be employed to suppress activity of 
CRH neurons and determine if the suppression effect of stress on LH surge is affected. 
Traditionally, the administration route for CNO (a ligand for DREADD receptor) is 
through intraperitoneal (ip) injection. However, data from my pilot studies with others in 
the lab show that ip injection could induce stress by raising corticosterone secretion in 
mice. Therefore, an alternative method to administer CNO that is less stressful is 
needed.  
 
The alternative approach that we tested is to use Nutella to deliver the CNO to mice. 
This method has been shown to be an effective way to administer estradiol in mice and 
rats (273,274). To verify if the Nutella method is capable of delivering CNO, mice with 
3Dq receptors expressing in CRH neurons (CRH-3Dq) were used. Mice were treated 
with Nutella-CNO following by serial blood samples for corticosterone measurement as 
an output of CRH neuron activity. Figure 4-2A showed that the corticosterone level in 
CNO-treated mice was higher than that of vehicle group but start to decline 1.5h after 
the treatment. In the vehicle-treated mice, the corticosterone level started to increase 
later in the day due to the diurnal rise of corticosterone, while the CNO-treated group 
did not show the diurnal increase of corticosterone. This result implies the negative 
feedback effect of corticosterone on CRH neurons in the CNO-treated group. This idea 
is supported by another set of experiment in CRH-3Dq mice treated by ip injection 
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method. Figure 4-2B showed that mice treated with CNO also did not show the diurnal 
increase in corticosterone. We further verified the Nutella-CNO method comparing to 
the traditional ip injection route in GnRH-3Dq mice and measured LH levels as an 
output of the system. Figure 4-3 showed that mice treated with CNO either with Nutella 
or ip injection method showed a similar increase in LH level 15min after the treatment. 
These results suggest that Nutella method is effective for delivering CNO and that the 
onset of actions can be rapid. Some modifications are still needed to solve the negative 
feedback issue and stress induced by a novel object during the Nutella treatment. After 
fine tuning the Nutella method, future experiment would use this approach with the 
CRH-4Di mice to suppress activity of CRH neurons and test if CRH is required for the 
suppression of LH surge. 
 
Summary 
The work in this dissertation provides increased understanding of the central 
mechanisms of how CRH interacts with the HPG axis in females. The discovery of both 
stimulatory and inhibitory effects of CRH on GnRH neurons are novel keys to look at the 
interaction between HPA and HPG axes in a new perspective. In the past, the 
stimulatory effects of stress are less well-known and were sometime are ignored. This 
work helps guide future research to explore the stimulatory effects of stress on 
reproductive system in more detail. The inhibitory pathways of CRH still remain to be 
explored to build a complete picture of how stress affects reproduction. 
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Figure 4-1. Schematic model of the actions of CRH on GnRH neurons. 
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Figure 4-2. Corticosterone levels in CRH-3Dq mice treated with either CNO or DMSO 
via the Nutella method (A) or intraperitoneal injection (B). 
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Figure 4-3. LH levels in GnRH-3Dq mice treated with either CNO or DMSO via the 
Nutella method or intraperitoneal injection.
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